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Abstract
Background: The most predominant beta2-integrin lymphocyte function-associated antigen-1
(LFA-1, CD11a/CD18, alphaLbeta2), expressed on all leukocytes, is essential for many adhesive
functions of the immune system. Interestingly, RTX toxin-producing bacteria specifically target this
leukocyte beta2-integrin which exacerbates lesions and disease development.
Results: This study reports the sequencing of the wild boar beta2-integrin CD11a and CD18
cDNAs. Predicted CD11a and CD18 subunits share all the main structural characteristics of their
mammalian homologues, with a larger interspecies conservation for the CD18 than the CD11a.
Besides these strong overall similarities, wild boar and domestic pig LFA-1 differ by 2 (CD18) and
1 or 3 (CD11a) substitutions, of which one is located in the crucial I-domain (CD11a, E168D).
Conclusion: As most wild boars are seropositive to the RTX toxin-producing bacterium
Actinobacillus pleuropneumoniae and because they have sustained continuous natural selection, future
studies addressing the functional impact of these polymorphisms could bring interesting new
information on the physiopathology of Actinobacillus pleuropneumoniae-associated pneumonia in
domestic pigs.
Background
Cell adhesion receptors play crucial roles in multicellular
organisms by mediating the direct cell/cell or cells/extra-
cellular matrix proteins interactions. These molecular
interactions condition the structural integrity of cells and
tissues and contribute to the signalling transduction inter-
vening in the cellular dynamic [1]. Cell adhesion recep-
tors are subdivided in several membrane-associated
protein families, including integrins, cadherins, immu-
noglobulin superfamily cell adhesion molecules,
selectins, and syndecans. Integrins are a family of cell sur-
face adhesion and signalling glycoproteins made up of
non-covalently associated 120–180 kDa α and 90-
110kDa β subunits [2]. There are 19 distinct α subunits
and 8 β subunits that are combined to form 25 different
heterodimeric receptors [1]. Each subunit possesses (i) a
large extracellular N-terminal domain associating with
that of the companion subunit to form the integrin head-
piece which contains the ligand binding site, (ii) a single
transmembrane stretch, and (iii) a short cytoplasmic C-
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ton and signalling proteins [1,3,4].
Within the integrin family, the leukocyte-specific β2-
integrins (CD11/CD18) include four members sharing in
common the β2 subunit (CD18) [5]: (i) the most predom-
inant is the lymphocyte function-associated antigen-1
(LFA-1, CD11a/CD18, αLβ2) on all leukocytes [6]; (ii) the
CD11b/CD18 (Mac-1, CR3, αMβ2) mainly on activated
granulocytes and tissues macrophages [7]; (iii) the
CD11c/CD18 (gp150/95, CR4, αXβ2, Leu-M5) also on
activated granulocytes and tissues macrophages [8], and
(iv) the CD11d/CD18 (αDβ2) abundant on the CD8+
lymphocyte and on macrophages [9-11]. These receptors
are essential for an effective immune system as observed
in repeated infections associated with the lymphocyte
adhesion deficiency (LAD) type I syndrome, a disease due
to mutations in the β2 (CD18) subunit gene leading to the
lack of functional β2 integrins on the membrane surface of
leukocytes [12-14].
The β2-integrin LFA-1 is essential for the following func-
tions of the immune system [15-20] : (i) interaction
between lymphocytes, (ii) interaction between T-cells and
antigen presenting cells, (iii) adhesion of naïve lym-
phocytes to post-capillary high endothelial venules of sec-
ondary lymphoid tissues, (iv) adhesion of leukocytes to
activated endothelium at sites of inflammation for
extravasation, (v) control of cell differentiation and prolif-
eration, and (vi) antibody-dependent killing by natural
killer cells and granulocytes. Leukocyte LFA-1-mediated
adhesion is engaged via the binding of the LFA-1 in an
activated conformational state to membrane proteins, the
so-called intercellular adhesion molecules (ICAM)-1 to -5
and the junctional adhesion molecule (JAM)-A [21].
Interestingly, several pathogens target the leukocytes β2-
integrins which leads to lesions and disease development
[22]. Several studies have highlighted the central role of
LFA-1 in the pathogenesis of diseases caused by repeats-
in-toxin (RTX)-producing bacteria. The virulence of Aggre-
gatibacter (Actinobacillus) actinomycetemcomitans (localised
aggressive periodontitis in humans), Mannheimia haemo-
lytica (pneumonia in cattle), and pathogenic strains of
Escherichia coli (extraintestinal infections) has been associ-
ated with a ligand/receptor interaction between their
respective RTX toxin (LtxA, LktA, and HlyA) and the
CD11a/CD18 receptor resulting in leukocytes alterations
[23-26]. This interaction triggers synthesis and release of a
wide array of cytokines and chemoattractants by the leu-
kocytes that exacerbate inflammation and ultimately
results in a much greater leukolysis worsening the lesions
[25,27]. Actinobacillus pleuropneumoniae, a causative agent
of pleuropneumonia in domestic pigs (Sus scrofa domes-
tica), responsible for economic losses and antibiotic usage
in the pork industry, also produces RTX toxins (ApxIA, -
IIA, -IIIA, and -IVA) [28,29]. We therefore hypothesize
that the pathogenesis of this disease similarly relies on an
interaction with the Sus scrofa domestica LFA-1, whose
CD11a (αL) and CD18 (β2) subunits have been well char-
acterised [30,31]. On the basis of the report that approxi-
mately 50% of wild boars in their natural environment are
serologically positive for Actinobacillus pleuropneumoniae
[32] and because these wild pigs sustain losses due to nat-
ural selection pressure, we hypothesize that some LFA-1
molecular peculiarities conferring resistance to wild boars
could have been selected. In this context, the purpose of
this study was to report the sequence and analysis of the
cDNAs encoding wild boar LFA-1 (WbCD11a/WbCD18)
and to point out the wild boar LFA-1 specificities that
might confer resistance to Actinobacillus pleuropneumoniae-
associated pneumonia.
Results and discussion
Characterization of WbCD11a-encoding cDNA and 
deduced amino-acid sequence
The WbCD11a cDNA sequence contains an ORF of 3519
bp [GenBank:EF585976] that codes for 1172 aa (Fig. 1).
Starting from the N-terminal end, the 1172 aa mature
WbCD11a contains a 23-residue putative leader peptide
(M1-S23), an extracellular domain of 1064 residues (Y24-
D1086), a single hydrophobic transmembrane region of 24
residues (M1087-Y1110) and a short cytoplasmic tail of 62
residues (K1111-A1172) (Fig. 1). Six N-linked putative glyc-
osylation sites (Asn-Xaa-Ser/Thr) are found in the extra-
cellular domain (Fig. 1). The WbCD11a possesses 22
cysteine residues, among which one is located in the cyto-
plasmic tail (Fig. 1). A subset of integrin α chains (α1, α2,α10, α11, αD, αE, αL, αM and αX), including CD11a, con-
tains a I-domain (for Inserted domain, also called αLI-
domain or αLA-domain) that is homologous to the family
of von Willebrand Factor (vWF) A-type domains and to
cartilage matrix protein [33,34]. The I-domain has been
associated with ligand binding. Its three-dimensional
structure consists of a five-stranded parallel β-sheet core
surrounded on both faces by seven α-helices (Fig. 1). A
short antiparallel strand occurs on one edge of this sheet
[35]. The I-domain (I149-D331) contains a metal ion-
dependent adhesion site (MIDAS) (residues D160-S164,
T229, D262) [35,36] (Fig. 1). The I-domain crystallisation
has demonstrated that a "closed" (low affinity) and an
"open" (high affinity) forms exist and that the major con-
formational changes during transition from the closed to
open states include a rearrangement of the cation-coordi-
nating residues in the MIDAS site, accompanied by a
small inward movement of the α1 helix and a large down-
ward shift of the mobile C-terminal α7 helix [37]. The
extracellular domain of WbCD11a contains seven internal
repeats (FG-GAP) (G40-T89, S90-E147, S348-R398, A399-Q453,
G455-D511, G513-F573, I576-P628) that surround the I-Page 2 of 12
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among the three COOH-terminal repeats (18–31%) and
their central region (D466-E474, D528-D536 and D588-D596)
is similar to the EF hand divalent cation-binding motifs
(DCBM) of troponin C, parvalbumin and galactose bind-
ing protein [38] (Fig. 1). All the cysteine residues and all
but one N-glycosylation sites are found outside the I-
region and divalent cation binding motifs (Fig. 1), con-
sistent with the hypothesis that these regions may
undergo conformational changes important in ligand
binding [38,40]. Between the FG-GAP 7 and the trans-
membrane domain stands the thigh domain (M629-K766),
the genu (N767-C774), and the CALF domains (E775-L920,
N921-D1086) [41]. The cytoplasmic portion of WbCD11a
contains four potential phosphorylation sites and also a
conserved "G1113FFKR" basic sequence near the trans-
membrane region (Fig. 1). The integrins become constitu-
tively active when this sequence is deleted. The
"G1113FFKR" motif thus normally fixes the integrins in an
inactive state [11,42].
Beside the complex mechanisms of affinity/avidity regula-
tion of the integrins, the existence of several isoforms
issued from alternative splicing complicates the biological
understanding of these glycoproteins [43]. Previously, we
have characterised two different forms of PoCD11a due to
the presence of a supplementary "cag" codon that codes
for a glutamine (Q) in position 744 [Gen-
Bank:DQ013284, GenBank:DQ013285] [31]. The addi-
tion of a Gln at the same position was also observed in the
human (Q746) [GenBank:NM_002209, Gen-
Bank:AY892236], the simian (Q746) [44], ovine (Q743)
[45] and caprine (Q743) [GenBank:AY773018, Gen-
Bank:AY773019] CD11a cDNAs (Fig. 2). This addition
located in the thigh domain of the extracellular part of
CD11a, just above the genu, increases the length of an α-
helix in the PoCD11a according to the GORIV bioinfor-
matic program. Until now, it was not clear whether this
addition represented two alleles or was generated by an
alternative splicing. We have recently cloned and
sequenced a third PoCD11a form characterised by an
The nucleotide and deduced amino acid sequences of wild boar CD11a cDNAFigure 1
The nucleotide and deduced amino acid sequences of wild boar CD11a cDNA.
                ¤ 
   1:  M  N  S  C  I  I  V  M  R  L  L  L  S  G  P  F  L  F  A  A  A  W  S  Y  N  L  D  V  R  H  V  Q  H  F  S  F  P  L  A  G  R  H  F  G  Y  R  V  L  Q  V  G  N  G  V  F  F :55
   1:  ATGAACTCCTGCATCATCGTGATGAGGCTGCTGCTGTCCGGGCCTTTTCTCTTTGCCGCCGCCTGGAGCTACAACCTGGACGTGCGGCACGTACAACACTTCTCCTTCCCACTCGCCGGCAGGCACTTTGGGTACCGTGTCCTGCAGGTTGGAAATGGGGTTTTC  :165 
                                                    ¤                    ¤                          #                                                                 ¤
  56:  V  G  A  P  G  E  G  N  S  M  G  S  L  Y  Q  C  Q  P  D  N  G  Q  C  M  Q  V  T  P  S  G  S  N  Y  T  S  K  Y  L  G  M  T  L  A  T  D  P  T  T  N  S  L  L  A  C  D  D :110 
 165:  GTGGGAGCTCCAGGTGAGGGGAACAGCATGGGAAGCCTCTATCAGTGTCAGCCAGACAATGGACAATGCATGCAAGTCACACCAAGTGGTTCCAACTATACCTCCAAGTACTTGGGAATGACCTTGGCGACAGATCCCACAACGAACAGTCTTTTGGCCTGTGAC  :330 
                         ¤                             ¤                                                              ¤                     β1                 MIDAS
 111:  P  G  L  S  R  T  C  D  Q  N  I  Y  L  S  G  L  C  Y  L  F  H  Q  G  L  G  G  P  V  L  Q  G  R  P  G  Y  Q  E  C  I  K  G  N  V  D  L  V  F  L  F  D  G  S  N  S  L  L :165 
 331:  CCTGGGCTGTCTCGGACATGTGATCAGAACATCTATCTAAGTGGCCTGTGTTACCTCTTCCACCAGGGCCTGGGGGGTCCTGTGCTGCAAGGGCGCCCTGGTTATCAGGAATGTATAAAGGGCAACGTGGACTTGGTATTTCTGTTTGATGGATCAAACAGCTTG  :495 
            (D)                   α1                               #                    β2                                            α2                        α3        
 166:  S  P  E  E  F  R  K  I  V  D  F  M  K  D  V  M  K  K  L  S  N  T  S  Y  Q  F  A  A  V  Q  F  S  T  T  Y  R  T  E  F  T  F  L  D  Y  A  K  Q  K  N  P  D  V  L  L  N  N :220 
 496:  AGTCCCGAAGAATTTCGGAAAATCGTGGACTTCATGAAGGATGTGATGAAGAAACTCAGCAACACTTCCTACCAGTTTGCTGCTGTTCAATTTTCCACAACCTACCGTACAGAATTTACTTTCTTGGATTATGCTAAACAGAAGAACCCGGATGTTCTGCTGAAT  :660 
                              MIDAS                    α4                                                           β3           MIDAS                            α5
 221:  N  V  K  H  M  R  E  L  T  N  T  F  G  A  I  D  Y  V  A  S  H  V  F  Q  Q  K  L  G  A  R  P  D  A  T  K  V  L  I  I  I  T  D  G  E  A  T  D  G  K  D  I  S  S  A  K  K :275 
 661:  AATGTCAAACACATGCGCGAGTTGACCAACACCTTTGGTGCCATCGACTATGTTGCGAGTCACGTGTTCCAGCAAAAGCTGGGGGCCCGTCCAGATGCCACAAAAGTGCTTATCATCATCACGGACGGGGAAGCCACCGACGGAAAGGACATCAGCTCCGCCAAG  :825 
                      β4                                              α6                                      β5                               α7          
 276:  D  I  V  R  Y  I  I  G  V  G  K  H  F  K  T  T  K  S  Q  E  T  L  H  Q  F  A  S  K  P  V  E  E  F  V  K  I  L  D  T  F  E  K  L  K  D  L  F  T  E  L  Q  K  K  I  Y  Y :330 
 826:  GACATCGTCCGCTACATCATTGGGGTCGGAAAGCATTTTAAGACCACGAAAAGTCAAGAAACACTTCACCAGTTTGCCTCAAAACCCGTGGAGGAGTTTGTAAAGATTCTGGACACGTTTGAGAAGCTGAAAGATCTATTCACCGAGCTTCAAAAAAAGATCTAT  :990 
 331:  D  I  E G  T  S  K  Q  D  L  T  S  F  D  M  E  L  S  S  S  G  I  S  A  D  L  S  K  G  H  G  I  V  G  A  V  G  A  E  D  W  A  G  G  F  L  D  L  K  A  D  L  Q  G  D    :385 
 991:  GACATTGAGGGCACAAGCAAACAGGACCTGACGTCCTTCGACATGGAGCTGTCCTCCAGCGGGATCAGCGCGGACCTCAGCAAGGGCCACGGCATCGTAGGGGCTGTCGGAGCCGAGGACTGGGCTGGGGGCTTCCTCGACCTGAAGGCAGACCTGCAGGGGGAT  :1155 
 386:  T  F  V  G  N  V  P  L  T  P  E  V  R  A  G  Y  L  G  Y  T  V  T  W  L  P  S  R  G  T  M  S  L  L  A  A  G  A  P  R  Y  Q  H  V  G  R  V  L  L  F  Q  K  P  E  D  K    :440 
1156:  ACATTTGTTGGGAATGTACCACTGACACCAGAAGTGAGGGCGGGATATTTGGGTTACACAGTGACCTGGCTGCCCTCCCGAGGAACCATGTCACTGCTGGCAGCTGGAGCCCCCCGGTACCAGCATGTGGGGCGGGTGCTGCTGTTCCAAAAACCAGAGGACAAA  :1320 
                                                                         ¤                   DCBM1
 441:  G  P  W  R  Q  I  Q  K  I  D  G  T  Q  I  G  S  Y  F  G  G  E  L  C  G  V  D  L  N  Q  D  G  E  T  E  L  L  L  I  G  V  P  L  F  Y  G  E  Q  R  G  G  R  V  F  V  Y    :495 
1321:  GGACCCTGGAGGCAGATCCAGAAAATAGATGGGACCCAGATTGGCTCTTATTTTGGAGGCGAGCTGTGTGGTGTCGACCTGAACCAAGATGGGGAGACAGAGCTGCTACTGATTGGAGTCCCCCTGTTCTATGGGGAGCAGAGAGGAGGCCGGGTATTCGTTTAC  :1485 
                                                                                                                 DCBM2
 496:  Q  R  K  Q  L  E  F  Q  M  I  S  E  L  H  G  D  P  G  Y  L  L  G  R  F  G  A  A  I  T  A  L  M  D  L  N  G  D  G  L  T  D  V  A  V  G  A  P  L  E  E  Q  G  A  V  Y    :550 
1486:  CAGAGAAAACAGCTGGAGTTCCAAATGATCTCAGAGCTACATGGGGATCCCGGCTACCTCCTTGGGCGATTTGGAGCAGCCATCACTGCCCTGATGGACCTCAATGGGGACGGGCTGACGGACGTGGCTGTGGGAGCCCCTCTGGAGGAGCAGGGGGCTGTGTAC  :1650 
                                                                                                                                DCBM3
 551:  I  F  N  G  K  P  G  G  L  S  A  W  P  S  Q  R  I  A  G  A  Q  M  F  S  E  I  R  W  F  G  R  S  I  H  G  V  K  D  L  G  G  D  G  L  A  D  V  A  V  G  A  E  G  Q  V    :605 
1651:  ATCTTCAATGGGAAGCCCGGGGGGCTGAGCGCCTGGCCCAGTCAGCGGATAGCGGGCGCCCAGATGTTCTCAGAAATTCGATGGTTTGGACGCTCCATCCACGGGGTGAAGGACCTTGGAGGGGATGGCCTGGCAGATGTGGCGGTGGGGGCGGAGGGCCAGGTG  :1815 
                                                   (E)                                     ¤                                                  ¤
 606:  I  V  L  S  S  R  P  V  V  D  I  N  T  T  I  D  F  S  P  A  E  I  P  M  H  E  V  E  C  S  Y  S  T  S  N  Q  K  K  E  G  V  N  L  I  V  C  F  Q  V  K  S  L  I  S  Q    :660 
1816:  ATCGTGCTGAGCTCCCGGCCTGTGGTGGACATCAACACGACCATCGACTTCTCCCCGGCCGAGATCCCAATGCACGAAGTCGAGTGCTCCTATTCAACCAGTAACCAGAAGAAGGAAGGCGTTAACCTCATAGTCTGCTTCCAGGTCAAGTCTCTCATCTCACAG  :1980 
                            #                                                                                                              ¤                             ¤
 661:  F  Q  G  P  L  V  A  N  L  T  Y  T  L  Q  L  D  G  H  R  T  R  S  R  G  L  F  P  G  G  T  H  E  L  S  G  N  T  A  V  T  S  D  Q  S  C  I  R  F  K  F  H  I  P  V  C    :715 
1981:  TTCCAAGGGCCCCTGGTTGCCAACCTCACTTACACTCTGCAGCTGGATGGGCATCGGACCAGAAGCCGGGGCTTGTTCCCAGGAGGGACCCATGAACTCAGCGGGAACACAGCTGTCACCTCAGACCAGTCCTGCATCAGATTCAAGTTCCACATCCCGGTATGC  :2145 
                               #           #                                                                                                                       ¤  
 716:  V  Q  D  L  I  S  P  I  N  V  S  L  N  Y  S  L  W  E  E  E  A  T  S  R  D  Q  R  A  D  K  D  I  Q  P  I  L  R  P  S  A  H  S  E  T  R  E  I  P  F  E  K  N  C  G  E    :770 
2146:  GTTCAAGACCTCATCTCGCCGATCAACGTCTCCCTAAATTACTCTCTCTGGGAGGAAGAAGCGACATCGAGGGACCAAAGGGCGGACAAGGACATCCAGCCCATCCTGAGACCCTCAGCACACTCAGAAACCAGGGAGATCCCTTTCGAGAAGAACTGTGGAGAG  :2310 
                ¤
 771:  D  K  K  C  E  A  D  L  R  V  A  F  S  P  E  S  S  K  V  L  R  L  T  P  S  T  S  L  A  V  R  L  T  L  Q  N  V  K  E  D  A  Y  W  V  H  L  S  L  S  F  P  W  G  L  S    :825 
2311:  GACAAGAAATGTGAGGCAGACCTGAGGGTGGCCTTCTCCCCTGAAAGCTCCAAAGTCCTGCGTCTGACCCCGTCCACCAGCCTCGCAGTGCGGCTGACACTGCAAAACGTGAAGGAAGACGCGTACTGGGTCCACCTCAGCCTGAGCTTCCCCTGGGGCCTCTCC  :2475 
                                                       ¤                                               ¤  #   
 826:  F  R  K  V  E  V  L  K  P  H  S  Q  M  P  V  S  C  E  E  L  L  E  E  T  S  L  Q  S  R  A  V  S  C  N  V  S  S  P  I  F  K  A  N  S  S  V  D  I  Q  V  M  F  D  T  L    :880 
2476:  TTCCGCAAAGTGGAGGTGCTCAAGCCTCACAGCCAGATGCCTGTGAGCTGCGAGGAGCTTCTGGAGGAGACCAGTCTTCAGAGCAGAGCCGTCTCCTGCAACGTGAGCTCTCCCATCTTCAAAGCAAACAGCTCGGTTGATATCCAGGTGATGTTTGATACGCTA  :2640 
                                                       ¤
 881:  S  N  S  S  W  E  D  L  V  E  L  K  A  D  V  R  C  N  N  E  D  T  G  H  L  I  D  N  W  A  A  T  S  I  P  V  L  Y  P  L  N  I  L  T  K  D  Q  E  N  S  T  L  Y  I  S    :935 
2641:  TCCAACAGCTCCTGGGAGGACCTTGTCGAGCTGAAGGCTGATGTGCGCTGCAACAACGAGGACACAGGCCACCTGATTGACAACTGGGCTGCCACCAGCATCCCGGTCCTGTACCCCCTCAACATCCTCACCAAGGACCAGGAAAACTCCACGCTGTATATCAGT  :2805 
 936:  F  T  P  K  G  P  K  T  H  H  V  K  H  S  Y  Q  V  K  I  Q  P  S  V  Y  D  H  N  M  P  A  L  E  A  L  V  G  V  P  Q  P  H  P  K  G  P  I  T  H  K  W  S  V  Q  M  E    :990 
2806:  TTCACCCCCAAAGGTCCCAAGACCCACCATGTCAAGCACAGCTACCAGGTGAAGATCCAGCCTTCTGTCTATGACCACAACATGCCTGCCCTGGAGGCCTTGGTTGGGGTACCACAGCCCCACCCCAAGGGGCCCATCACACACAAGTGGAGCGTGCAGATGGAG  :2970 
                   ¤                                               ¤                       ¤
 991:  P  P  V  T  C  H  Q  E  E  V  E  S  L  P  S  V  A  E  P  L  C  Q  L  G  A  Q  F  R  C  P  V  V  F  K  Q  E  I  L  V  Q  V  I  G  T  V  E  L  V  G  D  I  E  A  S  S    :1045 
2971:  CCTCCTGTCACCTGCCACCAGGAGGAGGTGGAGAGTCTGCCCAGTGTGGCTGAGCCGCTGTGTCAGCTTGGAGCCCAGTTCCGCTGCCCAGTTGTCTTCAAGCAGGAGATCCTCGTCCAAGTGATCGGGACAGTGGAGCTGGTGGGGGACATCGAGGCCTCCTCC  :3135 
                   ¤  
1046:  V  F  S  L  C  S  S  L  A  I  S  F  N  S  S  K  H  F  H  L  Y  G  S  N  A  S  L  A  Q  V  N  M  K  V  D  I  I  Y  E  K  D  M  L  Y  L  Y  V  L  S  S  I  G  G  L  L  L :1100 
3136:  GTGTTCAGCCTCTGCAGCTCCCTCGCCATCTCCTTCAACAGCAGCAAGCACTTCCACCTCTATGGCAGCAACGCCTCCCTCGCCCAGGTCAACATGAAGGTGGACATTATATACGAGAAGGACATGCTCTATCTCTACGTGCTGAGCAGCATCGGGGGGCTGTTG ::3300 
                                                                                              +        +              +              +                          ¤    
1101:  L  L  L  L  I  F  L  V  L  Y  K  V  G  F  F  K  R  N  L  K  E  Q  M  E  A  T  E  E  A  S  N  D  T  P  E  E  D  S  G  R  P  A  S  G  E  D  A  R  D  P  G  C  L  E  P    :1155 
3301:  CTGCTGCTGCTGATTTTCTTAGTTCTGTACAAGGTTGGCTTCTTTAAACGGAACCTGAAGGAGCAGATGGAAGCGACTGAAGAGGCTTCAAATGACACCCCGGAAGAAGACTCTGGGAGGCCAGCATCTGGGGAAGACGCCAGGGATCCGGGCTGCCTGGAGCCT  :3465 
1156:  L  H  N  D  N  T  Q  D  A  V  G  A  T  E  A  Q  A  *                                                                                                                   :1172 
3466:  CTCCACAACGACAACACCCAGGACGCAGTGGGAGCGACTGAAGCCCAGGCCTGA                                                                                                                 :3519 
Boxes framing the sequences represent the deduced different constitutive parts of the protein : the putative leader peptide ( ), the seven repeats that surround the αI-domain ( ) 
and the central divalent cation-binding motifs of the three COOH-terminal repeats ( ), the αI-domain ( ) with its MIDAS ( ), the thigh domain ( ), the genu 
( ), the CALF-1 ( ) and CALF-2 ( ) domains, the transmembrane region ( ) and the highly conserved “GFFKR” motif ( ). The important “I149KGN” motif, 
P215, E333, K1120 are framed in black boxes. Cysteine residues (¤), potential N-glycosylation sites (#), potential cytoplasmic-tail phosphorylation sites (+) and alleles E168D (D) and D621E 
(E) are marked at the top of the sequences. Sequence data have been deposited at GenBank under accession no. EF585976. Page 3 of 12
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(P744EPLQLSSTSSAASATLSRLPLLCAQQ770) [Gen-
Bank:DQ474234] which is predicted to lengthen the α-
helix further. The nucleotidic sequence of this insertion
corresponds to that of the 3'end of the adjacent bovine
and human intron 18 (79% and 70% of identity respec-
tively), suggesting that the insertion of the glutamine or of
the 27 amino acids-long stretch in position 744 of the
thigh domain comes from an alternative splicing rather
than from different alleles. Although these two insertions
were not observed in the WbCD11a yet and because of the
between-species conservation of this potential alternative
splicing site, we hypothesize that it can have a biological
importance for the mature CD11a, for example, in regu-
lating the ligand binding and signaling activity.
WbCD11a comparison among species
Overall, the general organization of wild boar (Sus scrofa),
porcine (Sus scrofa domestica) [31], bovine (Bos taurus)
[46], ovine (Ovis aries) [45], caprine (Capra hircus) [47],
human [38], simian (Pan troglodytes) [44], canine (Canis
familiaris) [GenBank:XM_547024], rat (Rattus norvegicus)
[GenBank:NP_001029170], and murine (Mus musculus)
[48] CD11a proteins is quite similar (Fig. 2). Comparison
between mature WbCD11a sequence and its porcine,
bovine, ovine, caprine, human, simian, canine, rat and
murine counterparts shows respectively overall 99%,
77%, 77%, 77%, 76%, 76%, 76%, 70% and 69% identity,
and 99%, 87%, 86%, 86%, 86%, 86%, 85%, 81%, and
80% similarity (BLOSUM62table) (Table 1). The highest
identity is found for the "G1113FFKR" motif, the genu, the
MIDAS motif and the transmembrane region and the low-
est for the cytoplasmic tail and the putative signal peptide
(Table 1). Although DCBM3 presents a weak identity, its
similarity score is high. The "G1113FFKR" sequence is
highly conserved which is consistent with the stabilizing
role of this motif for the alpha/beta complex, possibly
because of its direct involvement in heterodimer forma-
Comparison of the wild boar (Wb-), porcine (Po-), bovine (Bo-), ovine (Ov-), caprine (Cap-), human (Hu-), simian (Si-), canine (Can-), rat (Ra-) and murine (Mu-) αL subu its amino acids sequencesFigure 2
Comparison of the wild boar (Wb-), porcine (Po-), bovine (Bo-), ovine (Ov-), caprine (Cap-), human (Hu-), simian (Si-), canine 
(Can-), rat (Ra-) and murine (Mu-) αL subunits amino acids sequences.
                                                                                                                                                                           
WbCD11a    : -MNSCIIVMRL-LLSGPFLFAAAWSYNLDVRHVQHFSFPLAGRHFGYRVLQVGNGVFVGAPGEGNSMGSLYQCQPDNGQCMQVTPSGSNYTSKYLGMTLATDPTTNSLLACDPGLSRTCDQNIYLSGLCYLFHQGLGGPVLQGRPGYQEC :  148 
PoCD11a    : -MNSCIIVMRL-LLSGPFLFAAAWSYNLDVRHVQHFSFPLAGRHFGYRVLQVGNGVFVGAPGEGNSMGSLYQCQPDNGQCMQVTPSGSNYTSKYLGMTLATDPTTNSLLACDPGLSRTCDQNIYLSGLCYLFHQGLGGPVLQGRPGYQEC :  148 
BoCD11a    : -MNSCIIVLRL-LLSGPFVFAPAWSYNLDVRHVQNFSFPLAGRHFGYRVLQVGNGVVVGAPSEGNSMGNLYQCQPETGDCLPVTLS-SNYTSKYLGMTLATDPTSDNLLACDPGLSRTCDQNIYLSGLCYLIHENLRGPVLQGHPGYQEC :  147 
OvCD11a    : -MNSYTIVMRF-LLSGPFVFAPAWSYNLDVRHVQSFSFPLAGRHFGYRVLQVGNRVVVGAPNEGNRMGNLYQCQPETGDCLPVTLS-SSYTSKYLGMTLATDPTSGNLLACDPGLSRTCDQNIYLSGLCYLIHENLRGPVLQGYPGYQEC :  147 
CapCD11a   : -MNSCTIVMRF-LLSGPFVFAPAWSYNLDVRHVQNFSFPLAGRHFGYRVLQVGNRVVVGAPNEGNRMGNLYQCQPETGDCLPVTLS-SSYTSKYLGMTLATDPTSGNLLACDPGLSRTCDQNIYLSGLCYLIHENLRGPVLQGHPGYQEC :  147 
HuCD11a    : MKDSCITVMAMALLSGFFFFAPASSYNLDVRGARSFSPPRAGRHFGYRVLQVGNGVIVGAPGEGNSTGSLYQCQSGTGHCLPVTLRGSNYTSKYLGMTLATDPTDGSILACDPGLSRTCDQNTYLSGLCYLFRQNLQGPMLQGRPGFQEC :  150 
SiCD11a    : MKDSCITVMAMALLSGFFFFAPASSYNLDVRGARSFSPPRAGRHFGYRVLQVGNGVIVGAPGEGNSTGSLYQCQSGTGHCLPVTLRGSNYTSKYLGMTLATDPTDGSILACDPGLSRTCDQNTYLSGLCYLFRQNLQGPMLQGRPGFQEC :  150 
CanCD11a   : -MNSYIIITRL-LLSGPSLFALASGYNLEVRHVQNFSFPHAGRHFGYRVLQVGDRVVVGAPGEGNSTGNLYQCQPGTGHCLPVSLSGSNYTSKYLGMTLATDFISGKLLACDPGLSRTCDQNVYLSGLCYLFHQNLRGVVLQGRPGYQEC :  148 
RaCD11a    : -MSFRIPGPRLLLL-GLQLFVNAWSYNLDTRHAQSF-LTQAGRHFGYQVLQFGDGVVVGAPGEGNSTGNLYHCHPSSGSCQPVHL-GSNHTSKYLGMTMVTDAAKGSLLACDPGLSRTCDQNPYLSGLCYLFSQSLGKPILQNRPAYQEC :  146 
MuCD11a    : -MSFRIAGPRLLLL-GLQLFAKAWSYNLDTRPTQSF-LAQAGRHFGYQVLQIEDGVVVGAPGEGDNTGGLYHCRTSSEFCQPVSLHGSNHTSKYLGMTLATDAAKGSLLACDPGLSRTCDQNTYLSGLCYLFPQSLEGPMLQNRPAYQEC :  147 
                 ¤                             #                             #       ¤      ¤        #                     ¤       ¤         ¤                    ¤            
WbCD11a    : IKGNVDLVFLFDGSNSLSPDEFRKIVDFMKDVMKKLSNTSYQFAAVQFSTTYRTEFTFLDYAKQ-KNPDVLLNNVKHMRELTNTFGAIDYVASHVFQQKLGARPDATKVLIIITDGEATDGKDISSAKDIVRYIIGVGKHFKTTKSQETL :  297 
PoCD11a    : IKGNVDLVFLFDGSNSLSPEEFRKIVDFMKDVMKKLSNTSYQFAAVQFSTTYRTEFTFLDYAKQ-KNPDVLLNNVKHMRELTNTFGAIDYVASHVFQQKLGARPDATKVLIIITDGEATDGKDISSAKDIVRYIIGVGKHFKTTKSQETL :  297 
BoCD11a    : IKGNVDLVFLFDGSMSLQQDEFEKIVDFMKDVMKKLSNSSYQFAAVQFSTYFRTEFTFLDYIRQ-KDPDALLAGVKHMRLLTNTFGAINYVAKEVFRPDLGARPDATKVLIIITDGEATDEHNIDAAKDIIRYIIGIGKNFKTKESQEAL :  296 
OvCD11a    : IKGNVDLVFLFDGSMSLQQDEFEKIVDFMKDVMKKLSNSSYQFAAVQFSTDFKTEFTFLDYNRQ-KDPDALLAGVKHMRLLTNTFGAINYVAKEVFRQELGARPDATKVLIIITDGEATDEQNIDAAKDIIRYIIGIGKNFKTKESQEAL :  296 
CapCD11a   : IKGNVDLVFLFDGSMSLQQDEFGKIVDFMKDVMKKLSNSSYQFAAVQFSTDFKTEFTFLDYNRQ-KDPDALLAGVKHMRLLTNTFGAINYVAKEVFRQELGARPDATKVLIIITDGEATDEQNIDAAKDIIRYIIGIGKNFKTKESQEAL :  296 
HuCD11a    : IKGNVDLVFLFDGSMSLQPDEFQKILDFMKDVMKKLSNTSYQFAAVQFSTSYKTEFDFSDYVKR-KDPDALLKHVKHMLLLTNTFGAINYVATEVFREELGARPDATKVLIIITDGEATDSGNIDAAKDIIRYIIGIGKHFQTKESQETL :  299 
SiCD11a    : IKGNVDLVFLFDGSMSLQPDEFQKILDFMKDVMKKLSNTSYQFAAVQFSTSYKTEFDFSDYVKR-KDPDALLKHVKHMLLLTNTFGAINYVATEVFREELGARPDATKVLIIITDGEATDSGNIDAAKDIIRYIIGIGKHFQTKESQETL :  299 
CanCD11a   : IKGNVDLVFLFDGSMSLQQDEFQKILDFMKDVMKKLSNSSYQFAAVQFSTDCKTEFNFLDYVKV-KNPDVLLGKVVHMRLLTNTFGAINYVAREVFRQDLGARPDATKVLIIITDGEATDRANIDSAKDIIRYIIGIGKHFATKRSQETL :  297 
RaCD11a    : MKGNVDLVFLFDGSQSLDKKDFEKIVDFMKDVMRKLSNTSYQFAAVQFSTECKTEFTFLDYIKLNKNPDVLLGNVTPMFLLTNTFRAINYVVTHVFKEESGARPDATKVLVIITDGEASDNGNIDAAQDITRYIIGIGKHFSTTQKQEKL :  296 
MuCD11a    : MKGKVDLVFLFDGSQSLDRKDFEKILEFMKDVMRKLSNTSYQFAAVQFSTDCRTEFTFLDYVKQNKNPDVLLGSVQPMFLLTNTFRAINYVVAHVFKEESGARPDATKVLVIITDGEASDKGNISAAHDITRYIIGIGKHFVSVQKQKTL :  297 
                                                  #             ¤               $                                                      #                                       
WbCD11a    : HQFASKPVEEFVKILDTFEKLKDLFTELQKKIYDIEGTSKQDLTSFDMELSSSGISADLSKGHGIVGAVGAEDWAGGFLDLKADLQGDTFVGNVPLTPEVRAGYLGYTVTWLPSRGTMSLLAAGAPRYQHVGRVLLFQKPEDKGPWRQIQ :  447 
PoCD11a    : HQFASKPVEEFVKILDTFEKLKDLFTELQKKIYDIEGTSKQDLTSFDMELSSSGISADLSKGHGIVGAVGAEDWAGGFLDLKADLQGDTFVGNVPLTPEVRAGYLGYTVTWLPSRGTMSLLAAGAPRYQHVGRVLLFQKPEDKGPWRQIQ :  447 
BoCD11a    : HQFASKPVEEFVKILDTFEKLKDLFTELQKKIYVIEGTSKQDLTSFNMELSSSGISADLSEGHGVVGAVGAKDWAGGFLDLKADLKSSTFVGNEPLTVESRAGYLGYTVTWLPSRGTMSLLATGAPRYQHVGRVLLFQQPKRGGPWSQIQ :  446 
OvCD11a    : HQFASKPVEEFVKILDTFEKLKDLFTELQKKIYVIEGTSKQDLTSFNMELSSSGISADLSEGHGVVGAVGAKDWAGGFLDLKADLQSSTFVGNEQPTVESREGYLGYTVTWLPSRGMMSLLATGAPRYQHVGRVLLFQQPKRGGPWSQIQ :  446 
CapCD11a   : HQFASKPVEEFVKILDTFEKLKDLFTELQKKIYVIEGTSKQDLTSFNMELSSSGISADLSEGHGVVGAVGAKDWAGGFLDLKADLQSSTFVGNEQLTVESREGYLGYTVTWLPSRGTMSLLATGAPRYQHVGRVLLFQQPKRGGPWSQIQ :  446 
HuCD11a    : HKFASKPASEFVKILDTFEKLKDLFTELQKKIYVIEGTSKQDLTSFNMELSSSGISADLSRGHAVVGAVGAKDWAGGFLDLKADLQDDTFIGNEPLTPEVRAGYLGYTVTWLPSRQKTSLLASGAPRYQHMGRVLLFQEPQGGGHWSQVQ :  449 
SiCD11a    : HKFASKPASEFVKILDTFEKLKDLFTELQKKIYVIEGTSKQDLTSFNMELSSSGISADLSRGHAVVGAVGAKDWAGGFLDLKADLQDDTFIGNEPLTPEVRAGYLGYTVTWLPSREKTSLLASGAPRYQHVGRVLLFQEPQGGGHWSQVQ :  449 
CanCD11a   : HQFASKPAEEFVKILDTFEKLKDLFTELQKKIYVIEGTSKQDLTSFNMELSSSGLSADISQDRCIVGAVGAKDWAGGFLDLKADLQDDAFVGNEPLTPEARAGYLGYTVTWLYSRGLTSLLAAGAPRYQHVGRVVLFQESKDKEHWSQIQ :  447 
RaCD11a    : HIFASKPVEEFVKILDTFEKLKDLFTDLQRKIYAIEGTSKQDLASFNMELSSSGISADLSKGHAVVGAVGAKDWAGGFLDLHEDLEGATFVGQEPLTSDERGGYLGYTVAWLTSRSSRPLLAAGAPRYQHVGQVLLFQAPEAGGHWNQTQ :  446 
MuCD11a    : HIFASEPVEEFVKILDTFEKLKDLFTDLQRRIYAIEGTNRQDLTSFNMELSSSGISADLSKGHAVVGAVGAKDWAGGFLDLREDLQGATFVGQEPLTSDVRGGYLGYTVAWMTSRSSRPLLAAGAPRYQHVGQVLLFQAPEAGGRWNQTQ :  447 
                                                $                           ¤                                                                                               
                                                                                                                                                                           
WbCD11a    : KIDGTQIGSYFGGELCGVDLNQDGETELLLIGVPLFYGEQRGGRVFVYQRKQLEFQMISELHGDPGYLLGRFGAAITALMDLNGDGLTDVAVGAPLEEQGAVYIFNGKPGGLSAWPSQRIAGAQMFSEIRWFGRSIHGVKDLGGDGLADV :  597 
PoCD11a    : KIDGTQIGSYFGGELCGVDLNQDGETELLLIGVPLFYGEQRGGRVFVYQRKQLEFQMISELHGDPGYLLGRFGAAITALMDLNGDGLTDVAVGAPLEEQGAVYIFNGKPGGLSAWPSQRIAGAQMFSEIRWFGRSIHGVKDLGGDGLADV :  597 
BoCD11a    : EIDGIQIGSYFGGELCGVDVDRDGETELLLIAAPLYYGEQRGGRVFIYQKIQLEFQMVSELQGETGYPLGRFGAAIAALTDINGDELTDVAVGAPLEEQGAVYIFNGQQGGLSPRPSQRIEGTQMFSGIQWFGRSIHGVKDLGGDGLADV :  596 
OvCD11a    : KIDGIQVGSYFGGELCGVDVDRDGETELLLIAAPLYYGEQRGGRVFIYQKIQLGFQMVSELQGETGYPLGRFGAAIAALTDINGDELTDVAVGAPLEDQGAVYIFNGQQGGLSPRPSQRIEGTQMFSGIQWFGRSIHGVKDLGGDGLADV :  596 
CapCD11a   : KIDGIQVGSYFGGELCGVDVDRDGETELLLIAAPLYYGEQRGGRVFIYQKIQLGFQMVSELQGETGYPLGRFGAAIAALTDINGDELTDVAVGAPLEEQGAVYIFNGQQGGLSPRPSQRIEGTQMFSGIQWFGRSIHGVKDLGGDGLADV :  596 
HuCD11a    : TIHGTQIGSYFGGELCGVDVDQDGETELLLIGAPLFYGEQRGGRVFIYQRRQLGFEEVSELQGDPGYPLGRFGEAITALTDINGDGLVDVAVGAPLEEQGAVYIFNGRHGGLSPQPSQRIEGTQVLSGIQWFGRSIHGVKDLEGDGLADV :  599 
SiCD11a    : TIHGTQIGSYFGGELCGVDMDQDGETELLLIGAPLFYGEQRGGRVFIYQRRQLGFEEVSELQGDPGYPLGQFGEAITALTDINGDGLVDVAVGAPLEEQGAVYIFNGRHGGLSPQPSQRIEGTQVLSGIQWFGRSIHGVKDLEGDGLADV :  599 
CanCD11a   : KIDGNQIGSYFGGELCGVDIDQDGETELLLIGAPLFYGEQRGGRVFIYQRKQLGFEAVSELQGEPGYPLGRFGAAITALTDINGDGLVDVAVGAPLEEKGAVYIFNGQHGGLSPQPSQRIEGIQVFSGIQWFGRSIHGVKDLGGDGLTDV :  597 
RaCD11a    : KIEGTQIGSYFGGELCSVDLHQDGETDLLLIGAPLFYGEQRGGRVSVYQRRRSLFEMVSELQGDPGYPLGRFGAAISALTDINGDGLTDVAVGAPLEEQGAVYIFNGKPGGFSSQSSQRIPGTQVSPGVRWFGRSIHGVKDLGGDRLADV :  596 
MuCD11a    : KIEGTQIGSYFGGELCSVDLDQDGEAELLLIGAPLFFGEQRGGRVFTYQRRQSLFEMVSELQGDPGYPLGRFGAAITALTDINGDRLTDVAVGAPLEEQGAVYIFNGKPGGLSPQPSQRIQGAQVFPGIRWFGRSIHGVKDLGGDRLADV :  597 
                            ¤                                                                                                                                               
                                                                                                                                                                            
WbCD11a    : AVGAEGQVIVLSSRPVVDINTTIEFSPAEIPMHEVECSYSTSNQKKEGVNLIVCFQVKSLISQFQGPLVANLTYTLQLDGHRTRSRGLFPGGTHELSGNTAVTSDQSCIRFKFHIPVCVQDLISPINVSLNYSLWEEEATSRDQRA-DKD :  746 
PoCD11a    : AVGAEGQVIVLSSRPVVDINTTIDFSPAEIPMHEVECSYSTSNQKKEGVNLIVCFQVKSLISQFQGPLVANLTYTLQLDGHRTRSRGLFPGGTHELSGNTAVTSDQSCIRFKFHIPVCVQDLISPINVSLNYSLWEEEGTSRDQRAQDKD :  747 
BoCD11a    : AVGAEGQVIVLSSRPVVDIITSVSFSPAEIPVHEVECSYSTSNQKKEGVNLTVCFQVKSLISTFQGHLVANLTYTLQLDGHRTRSRGLFPGGKHKLIGNTAVTPVKSCFVFWFHFPICIQDLISPINVSLSYSLWEEEGTPRDPRALDRD :  746 
OvCD11a    : AVGAEGQVIVLSSRPVVDIITSMSFSPAEIPVREVECSYSTSNQEKEGVNITVCFQVKSLISTFEGHLVANLTYTLQLDGHRTRSRGLFPGGKHELNGNTAVTSVKSCFMFWFHFPICIQDLISPINVSLSYSLWEEEGTPRDPRAQGRD :  746 
CapCD11a   : AVGAEGQVIVLSSRPVVDIITSVSFSPAEIPVREVECSYSTSNQEKEGVNITVCFQVKSLISTFQGHLVANLTYTLQLDGHRTRSRGLFPGGKHELNGNTAVTSVKSCFMFWFHFPICIQDLISPINVSLSYSLWEEEGTPRDPRAQGRD :  746 
HuCD11a    : AVGAESQMIVLSSRPVVDMVTLMSFSPAEIPVHEVECSYSTSNKMKEGVNITICFQIKSLIPQFQGRLVANLTYTLQLDGHRTRRRGLFPGGRHELRRNIAVTTSMSCTDFSFHFPVCVQDLISPINVSLNFSLWEEEGTPRDQRAQGKD :  749 
SiCD11a    : AVGAESQMIVLSSRPVVDVVTLMSFSPAEIPVHEVECSYSTSNKMKEGVNITICFQIKSLIPQFQGRLVANLTYTLQLDGHRTRRRGLFPGGRHELRRNIAVTTSMSCTDFSFHFPVCVQDLISPINVSLNFSLWEEEGTPRDQRAQGKD :  749 
CanCD11a   : AVGAEGQVIVLSSRPVVDILTHISFSPAEIPVHEVECSHSTSNKKKEGVNITVCFQVKPLTLQFRGRLVANLIYTLQLDGHRTRSRGLFPGGRQELSGNIAVTRDWSCIKLWFHFPVCIQDLISPINVSLNFSLWEEEETPRNKRALDRD :  747 
RaCD11a    : VVGAEGQVIVLSSRPVVDIVTELSFSPDEIPVHEVECSYSASQEQKEGVKLKVCFQIRPLTSQFQGRLLANLSYTLQLDGHRTRSRGLFPGGSRELGGNTFVTPDRSCMDFHFHFPICIQDLISPINVSLNFSLLEEEGSPRDQKG-GRD :  745 
MuCD11a    : VVGAEGRVVVLSSRPVVDVVTELSFSPEEIPVHEVECSYSAREEQKHGVKLKACFRIKPLTPQFQGRLLANLSYTLQLDGHRMRSRGLFPDGSHELSGNTSITPDKSCLDFHFHFPICIQDLISPINVSLNFSLLEEEGTPRDQKG--RA :  745 
                                                 ¤            #   ¤                #                           #        ¤         ¤        #   #               =               
WbCD11a    : IQPILRPSAHSETREIPFEKNCGEDKKCEADLRVAFSPESSKVLRLTPSTSLAVRLTLQNVKEDAYWVHLSLSFPWGLSFRKVEVLKPHSQMPVSCEELLEETSLQSRAVSCNVSSPIFKANSSVDIQVMFDTLSNSSWEDLVELKADVR :  896 
PoCD11a    : IQPILRPSAHSETREIPFEKNCGEDKKCEADLRVAFSPESSKVLRLTPSTSLAVRLTLQNVKEDAYWVHLSLSFPWGLSFRKVEVLKPHSQMPVSCEELLEETSLQSRAVSCNVSSPIFKANSSVDIQVMFDTLSNSSWEDLVELKADVR :  897 
BoCD11a    : IPPILKPSPHLETKEIPFEKNCGEDKNCEADLKLAFSDMRSKILRLTPSASLSVRLTLRNTAEDAYWVQVTLSFPQGLSFRKVEILKPHSHVPVGCEELPEEAVVHSRALSCNVSSPIFGEDSMVDIQVMFNTLQKGSWGDFIELQANVS :  896 
OvCD11a    : IQPILKPSPHLETKEIPFEKNCGEDKTCEADLKLAFSDMRSKILHLTPSASLSVRLTLRNTAEDAYWVQVTLSFPQGLSFRKVEALKPHSHVPVGCEELPEEAILQSRALSCNVSSPIFGADSMVDIQVMFNTLQKGSWGDLIELHANVS :  896 
CapCD11a   : IPPILKPSPHLETKEIPFEKNCGEDKTCEADLKLAFSDMRSKILHLTPSASLSVRLTLRNTAEDAYWVQVTLSFPQGLSFRKVEALKPHSHVPVGCEELPEEAILQSRALSCNVSSPIFGADSMVDIQVMFNTLQKGSWGDLIKLHANVS :  896 
HuCD11a    : IPPILRPSLHSETWEIPFEKNCGEDKKCEANLRVSFSPARSRALRLTAFASLSVELSLSNLEEDAYWVQLDLHFPPGLSFRKVEMLKPHSQIPVSCEELPEESRLLSRALSCNVSSPIFKAGHSVALQMMFNTLVNSSWGDSVELHANVT :  899 
SiCD11a    : IPPILRPSLHSETWEIPFEKNCGEDKKCEANLRVSFSPARSRALRLTAFASLSVELSLSNLEEDAYWVQLDLHFPPGLSFRKVEMLKPHSQIPVSCEELPEESRLLSRALSCNVSSPIFKAGHSVALQMMFNTLVNSSWGDSVELRANVT :  899 
CanCD11a   : IRPILRPLPHVANTEIPFEKNCGEDKKCEADLGLSFSPAGSRVLRLIPSASLSVELILSNLREDAYSVHLNLSFPQGLSFRKVEMLKPHSQIPVSCEELPEVAKLMNRIVSCNVSSPIFRAGSVVAIQVMFHMLLNSSWGDSVELHANVS :  897 
RaCD11a    : MQPILRPSIHAVTKEIPFEKNCGEDKKCEADLALS-PPARSGVLRLMSSASLAVEWTLRNLGEDAYWVRLDLDFPRGLSFRKVEMLQPHSQIPVSCEELTEESSLLTKTLKCNVSSPIFKAGKQMTLQVMFNTLLNSSWGDFVELNGTVH :  894 
MuCD11a    : MQPILRPSIHTVTKEIPFEKNCGEDKKCEANLTLS-SPARSGPLRLMSSASLAVEWTLSNSGEDAYWVRLDLDFPRGLSFRKVEMLQPHSRMPVSCEELTEGSSLLTKTLKCNVSSPIFKAGQEVSLQVMFNTLLNSSWEDFVELNGTVH :  894 
                                  ¤     ¤  #                                                                ¤               ¤                                 #                
WbCD11a    : CNNEDTGHLIDNWAATSIPVLYPLNILTKDQENSTLYISFTPKGPKTHHVKHSYQVKIQPSVYDHNMPALEALVGVPQPHPKGPITHKWSVQMEPPVTCHQEEVESLPSVAEPLCQLGAQFRCPVVFKQEILVQVIGTVELVGDIEASSV : 1046 
PoCD11a    : CNNEDTGHLIDNWAATSIPVLYPLNILTKDQENSTLYISFTPKGPKTHHVKHSYQVKIQPSVYDHNMPALEALVGVPQPHPKGPITHKWSVQMEPPVTCHQEEVESLPSVAEPLCQLGAQFRCPVVFKQEILVQVIGTVELVGDIEASSV : 1047 
BoCD11a    : CNNEDSSLLEDNSATTSIPVMYPINVLTKDQENSTLYISFTPKSPKIHHVKHIYQVRIQPSNYD-NMPPLEALVRVPRVHSEGLITHKWSIQMEPPVNCSPRNLESPSDEAES-CSFGTEFRCPIDFRQEILVQVNGMVELRGTIKASSM : 1044 
OvCD11a    : CDNENSSLLEDNSATASIPVMYPINILTKDQENSTLYISFTPKSPKIHHVKHIYQVRIQPSNYD-NVPPLEALVRVPRVHSEGLITHRWSIQMEPPVNCSPRNLESPSDVAEP-CSFGTEFRCPIDFRQEILVQVNGTVELRGTIKASSM : 1044 
CapCD11a   : CDNENSSLLEDNSATASIPVMYPINILTKDQENSTLYINFTPKSPKIHHVKHIYQVRIQPSNYD-NVPPLEALVRVPQVHSEELITHRWSIQMEPPVNCSSRNLESPSDVAEP-GSFGTEFRCPIDFRQEILVQVNGTVELRGTIKASSM : 1044 
HuCD11a    : CNNEDSDLLEDNSATTIIPILYPINILIQDQEDSTLYVSFTPKGPKIHQVKHMYQVRIQPSIHDHNIPTLEAVVGVPQPPSEGPITHQWSVQMEPPVPCHYEDLERLPDAAEP-CLPGALFRCPVVFRQEILVQVIGTLELVGEIEASSM : 1048 
SiCD11a    : CNNEDSDLLEDNSATTIIPILYPINILIQDQENSTLYVSFTPKGPKIHQVKHMYQVRIQPSIHDHNIPTLEAVVGVPQPPSQGPITHQWSVQMEPPVPCHYEDLERLPDAAEP-CLPGALLRCPVVFRQEILVQVIGTLELVGEIEASSM : 1048 
CanCD11a   : CHNEDSGLLENNLATTTIPVLYPINILTEDKENSTLYVGFTPKGPKMYFVEHFYQVRIQPSIYDHKVPALEALIGVPVSHSEGPITHKWNVEMEPPVTCYREDLDRLPSVAEP-CLPGARFHCPFVYKEEIFVKVIGTIELVEKIEASSM : 1046 
RaCD11a    : CENENSSLGKDNSATTRIPVLYPVNILTEDQENSTLYISFTPKGPKTQQVQHIYKVRIQPSAYDHNMPALEALVEVPQPHSEGPIAHTWTVHTDPLVTCHCEDLKKPTREAE-PCLPGVQFRCPIVFRQETFIRVAGTVELSEKIKASST : 1043 
MuCD11a    : CENENSSLQEDNSAATHIPVLYPVNILTKEQENSTLYISFTPKGPKTQQVQHVYQVRIQPSAYDHNMPTLEALVGVPRPHSEDLITYTWSVQTDPLVTCHSEDLKRPSSEAEQPCLPGVQFRCPIVFRWEILIQVTGTVELSKEIKASST : 1044 
             ¤   #                           #                                                                 ¤               ¤       ¤                                      
                                                                                                                                                    
WbCD11a    : FSLCSSLAISFNSSKHFHLYGSNASLAQVNMKVDIIYEKDMLYLYVLSSIGGLLLLLLIFLVLYKVGFFKRNLKEQMEATEEASNDTPEEDSGRPAS-GEDARDPGCLEPLHNDNTQDAVGATEAQA : 1172 
PoCD11a    : FSLCSSLAISFNSSKHFHLYGSNASLAQVNMKVDIIYEKDMLYLYVLSSIGGLLLLLLIFLVLYKVGFFKRNLKEQMEATEEASNDTPEEDSGRPAS-GEDARDPGCLEPLHNDNTQDAVGATEAQA : 1173 
BoCD11a    : LSLCSSLAISFNSSKHFHLYGRNASMAQVVMKVDLVYEKEMLYLYVLSGIGGLLLLFLIFIALYKVGFFKRNLKEKMEANVDASSEIPGEDAGQPEL-EKECKDPGCLEPLQKTD-EDGSGGD---- : 1165 
OvCD11a    : LSLCSSLSISFNSSKHFHLYGSNASMAQVVMKVDLVYEKKMLYLYVLSGIGGLLLLLLIFIALYKVGFFKRNLKEKMEANVDASSEIPGEDAGQPEL-EKEFKDPGCLEPLQKED-EDGSGGD---- : 1165 
CapCD11a   : LSLSSSLSISFNSSKHFHLYGSNASMAQVVMKVDLVYEKKMLYLYVLSGIGGLLLLLLIFIALYKVGFFKRNLKEKMEANVDASSEIPAEDAGQPEL-EKEFKDPGCLEPLQKKD-EDESGGD---- : 1165 
HuCD11a    : FSLCSSLSISFNSSKHFHLYGSNASLAQVVMKVDVVYEKQMLYLYVLSGIGGLLLLLLIFIVLYKVGFFKRNLKEKMEAGRGVPNGIPAEDSEQLAS-GQEAGDPGCLKPLHEKDSESGGGKD---- : 1170 
SiCD11a    : FSLCSSLSISFNSSKHFHLYGSNASLAQVVMKVDVVYEKQMLYLYVLSGIGGLLLLLLIFIVLYKVGFFKRNLKEKMEAGRGVPNGIPAEDSEQLAS-GQEAGDPGCLKPLHEKDSESGGGKD---- : 1170 
CanCD11a   : VSLCSSLSVSFNSIKHFHLYGSNASMAQVVMKVDIIYEKEMLHVYALSSIGGLLLLLLIFVALYKLGFFKRNLKEKMEAVEA-SNEIPKQDSEQPVS-KEEAGDPGCLEPLQEGEAQDEAVKD---- : 1167 
RaCD11a    : LSLCSSLSVSFNSSKHFHLYGSKASKAQVLMKVDMIYEKEMLHLYVLSGIGGLLLLSLIFLALYKVGFFKRKLKEKMEADGGVPNGSPGEDADPLAVPGEETKDMGCLEPL-RESDKD--------- : 1160 
MuCD11a    : LSLCSSLSVSFNSSKHFHLYGSKASEAQVLVKVDLIHEKEMLHVYVLSGIGGLVLLFLIFLALYKVGFFKRNLKEKMEADGGVPNGSPPEDTDPLAVPGEETKDMGCLEPSGRVTRTKA-------- : 1163 
                ¤                                                                     £         +  +    +    +    ¤    ¤   +   ++ + +                     
Black columns with white letter represent identity among the 10 species. Cysteine residues (¤), potential N-glycosylation sites (#) and potential cytoplasmic-tail phosphorylation sites (+) are marked at the 
bottom of the sequences in red for 100% identity and in blue for less. The important P215, E333 and K1120 residues are marked by (£) in red for 100% identity and in blue for less and the Q744 residue is 
identified by (=). The stripes above the sequences represent the deduced different constitutive parts of the protein: the signal peptide ( ), the extracellular domain ( ), the seven repeats that 
surround the αI-domain ( , ) and the central divalent cation-binding motifs of the three COOH-terminal repeats ( ), the αI-domain ( ) and its metal-ion dependent adhesion site 
( ), the thigh domain ( ), the genu ( ), the CALF-1 ( ) and CALF-2 ( ) domains, the transmembrane region ( ), the cytoplasmic tail ( ) and the highly 
conserved “GFFKR” motif ( ). Page 4 of 12
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BMC Veterinary Research 2007, 3:27 http://www.biomedcentral.com/1746-6148/3/27tion [42]. The genu seems to play a key role in the activa-
tion of the LFA-1 through the deployment of the receptor
[41] and its great conservation is therefore not surprising.
The high conservation of the MIDAS and the putative cat-
ion binding motifs is consistent with an involvement of
these regions in the functional activity of the LFA-1 α sub-
unit, as suggested by the requirement of Mg2+ and Ca2+ for
CD11a/CD18-dependent cellular interactions [40] or
Table 1: Between-species percent identities and similarities of CD11a constitutive blocks






































































































































































































































































































































































































































Wb, Po, Bo, Ov, Cap, Hu, Si, Can, Ra, and Mu: wild boar, porcine, bovine, ovine, caprine, human, simian, canine, rat, and murine CD11a, respectively 
; FG-GAP : β-propeller repeat; MIDAS: metal-ion dependent adhesion site ; DCBM : divalent-cation binding motif ; vs : versus. (1) identity; (2) 
similarity (BLOSUM62 table).Page 5 of 12
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BMC Veterinary Research 2007, 3:27 http://www.biomedcentral.com/1746-6148/3/27binding to purified ICAM-1 [49,50]. The transmembrane
region also shows a high degree of conservation, probably
due to shared physicochemical and functional con-
straints. Indeed, residues lying in the membrane first have
to possess a hydrophobic character to warrant liposolubil-
ity, which is confirmed by the presence of many leucine
residues (Fig. 2). Secondly, bidirectional integrin signal-
ling (inside-out and outside-in) is accomplished by trans-
mission of information across the plasma membrane
[51]. By contrast, the low conservation of the COOH-ter-
minal part of the cytoplasmic tail suggests that it is not
required to guarantee adequate functioning of LFA-1. This
is in agreement with the observation that truncation of the
LFA-1 α subunit cytoplasmic domain has no effect on
binding to ICAM-1, whereas binding is markedly dimin-
ished by β subunit cytoplasmic domain truncation [52].
The "I149KGN" motif known to participate in the binding
to ICAM-3 [53] shows a high degree of conservation (Fig.
2). The amino acid P215, participating to the binding to
ICAM-1 [36] is highly conserved too (Fig. 2). Residue E333,
located in the linker following the I domain which is crit-
ical for communication with the β2 I-like domain, rolling,
integrin extension and activation by Mn2+ [16] is logically
strictly conserved too. The K1120 residue, critical for Rap1-
dependent LFA-1 activation and affinity up-regulation [5]
is also strongly conserved (Fig. 2). Every cysteine residue
in the mature WbCD11a is present at the same location in
bovine, ovine, human, simian, and murine CD11a, which
is consistent with a role in maintaining the global struc-
ture of the protein. Finally, of six potential Asn-glycosyla-
tion sites in WbCD11a, the ones present at amino acids
186 and 724 are strictly conserved (Fig. 2). In addition,
although WbCD11a sequences were obtained from only
four wild boars, one of them was heterozygous. Both alle-
les differed from those found in pigs by a G736A substitu-
tion. One allele displayed 2 additional substitutions
compared to pigs: E168D (in the I-domain) and D621E
(in the FG-GAP7, Fig. 1). According to the BLOSUM 62
table, these substitutions are theoretically predicted to
have a weak impact on the general structure of CD11a.
The nucleotide and deduced amino acid sequences of wild boar CD18 cDNAFigure 3
The nucleotide and deduced amino acid sequences of wild boar CD18 cDNA.
             ¤     ¤                                                           ¤                       ¤        ¤                    ¤        ¤           #                          
   1:  M  L  C  R  C  S  P  L  L  L  L  V  G  L  L  T  L  R  S  A  L  S  Q  E  C  A  K  Y  K  V  S  T  C  R  D  C  I  E  S  G  P  G  C  A  W  C  Q  K  L  N  F  S  G  Q  G  G :55    
   1:  ATGCTGTGCCGGTGCTCCCCGCTGCTCCTCCTGGTGGGCCTGCTCACCCTCCGGTCCGCCCTCTCCCAGGAGTGTGCCAAGTACAAGGTCAGCACCTGCCGGGACTGCATTGAGTCGGGACCCGGCTGTGCCTGGTGCCAGAAGCTGAACTTCTCTGGGCAAGGG  :165   
                         ¤                                ¤                                                                                                                       
  56:  E  P  D  S  V  R  C  D  T  R  E  Q  L  L  A  K  G  C  V  A  D  D  I  V  D  P  R  S  L  A  E  T  Q  E  D  Q  A  G  G  Q  K  Q  L  S  P  Q  K  V  T  L  Y  L  R  P  G   G:110   
 166:  GAGCCCGACTCCGTCCGCTGTGACACGCGGGAGCAGCTGCTTGCAAAGGGCTGTGTCGCGGATGACATCGTGGATCCCAGGAGCCTGGCCGAGACCCAGGAGGACCAGGCAGGGGGCCAGAAGCAGCTGTCCCCACAGAAAGTGACACTCTACCTGAGACCAGGT  :330   
                      #                                          β1               MIDAS          ADMIDAS   α1                          α1’                                 
 111 : Q  A  A  T  F  N  V  T  F  R  R  A  K  G  Y  P  I  D  L  Y  Y  L  M  D  L  S  Y  S  M  L  D  D  L  I  N  V  K  K  L  G  G  D  L  L  R  A  L  N  E  I  T  E  S  G  R  R :165   
 331:  CAGGCGGCCACGTTCAACGTGACCTTCCGGCGCGCCAAGGGCTACCCCATCGACCTGTACTACCTGATGGACCTGTCCTACTCCATGCTCGACGACCTCATCAACGTGAAGAAGCTGGGGGGCGACCTGCTCAGGGCTCTCAACGAGATCACCGAGTCTGGCCGC  :495   
             β2             LIMBS                                                  ¤                    ¤                  β3                                    α2                  
 166:  I  G  F  G  S  F  V  D  K  T  V  L  P  F  V  N  T  H  P  E  K  L  R  N  P  C  P  N  K  E  K  E  C  Q  A  P  F  A  F  R  H  V  L  K  L  T  D  N  S  N  Q  F  Q  T  E   E:220   
 496:  ATCGGCTTTGGGTCTTTCGTGGACAAGACGGTGCTTCCCTTCGTCAACACGCACCCCGAGAAGCTGCGGAACCCCTGCCCCAACAAAGAGAAGGAGTGCCAGGCCCCGTTCGCCTTCCGGCACGTGCTCAAGCTCACGGACAACTCCAACCAGTTCCAGACGGAG  :660   
                                     LIMBS                       α3               ¤      α4                #              β4             MIDAS                                         
 221:  V  G  K  Q  L  I  S  G  N  L  D  A  P  E  G  G  L  D  A  M  M  Q  V  A  A  C  P  E  E  I  G  W  R  N  V  T  R  L  L  V  F  A  T  D  D  G  F  H  F  A  G  D  G  K  L  L :275   
 661:  GTCGGGAAGCAGCTGATCTCGGGGAACCTGGACGCCCCCGAGGGCGGGCTGGATGCCATGATGCAGGTGGCCGCGTGCCCGGAGGAGATCGGCTGGCGCAACGTCACCAGGCTGCTGGTGTTCGCCACGGACGATGGCTTCCACTTTGCGGGCGACGGGAAGCTG  :825   
                                      ¤                                                                  α5                                β5                                    
 276:  G  A  I  L  T  P  N  D  G  R  C  H  L  E  D  N  L  Y  K  S  S  N  E  F  D  Y  P  S  V  G  Q  L  A  H  K  L  A  E  S  N  I  Q  P  I  F  A  V  T  K  K  M  V  K  T  Y  Y :330   
 826:  GGCGCCATCCTGACCCCCAACGACGGCCGCTGCCACCTGGAAGACAACTTATACAAAAGCAGCAATGAATTCGACTACCCATCAGTGGGACAGCTGGCACACAAACTGGCCGAGAGCAACATCCAGCCCATCTTTGCCGTGACCAAGAAAATGGTGAAAACGTAT  :990   
            α6                            β6          ADMIDAS                          α7                                                                                            
 331:  E  K  L  T  D  I  I  P  K  S  A  V  G  E  L  S  E  D  S  S  N  V  V  Q  L  I  K  N  A  Y  N  K  L  S  S  R  V  F  L  D  H  N  A  L  P  D  T  L  K  V  T  Y  D  S  F   F:385   
 991:  GAGAAGCTCACAGACATCATCCCCAAGTCCGCCGTCGGGGAGCTGTCGGAGGATTCCAGCAACGTGGTCCAGCTCATTAAGAACGCCTACAATAAACTGTCCTCCAGAGTGTTTTTGGATCACAACGCCCTCCCTGACACCCTGAAGGTCACGTACGACTCCTTC  :1155  
       ¤                                         ¤                                                           ¤                                                                     
 386:  C  S  N  G  V  S  Q  V  N  Q  P  R  G  D  C  D  G  V  Q  I  N  V  P  I  T  F  Q  V  K  V  T  A  S  E  C  I  Q  E  Q  S  F  V  I  R  A  L  G  F  T  D  T  V  T  V  R   R:440   
1156:  TGCAGCAACGGGGTGTCGCAGGTGAACCAGCCCAGAGGGGACTGCGACGGCGTCCAGATCAACGTCCCGATCACCTTCCAGGTGAAGGTCACCGCCTCCGAGTGCATCCAGGAGCAGTCGTTCGTCATCCGGGCGCTGGGCTTCACCGACACGGTGACCGTGCGG  :1320  
                   ¤     ¤     ¤                             ¤                       ¤        ¤     ¤                          ¤     ¤                                               
 441:  V  L  P  Q  C  E  C  R  C  G  D  S  S  K  E  R  S  L  C  G  N  K  G  S  M  E  C  G  V  C  R  C  D  A  G  Y  I  G  K  H  C  E  C  Q  T  Q  G  R  S  S  Q  E  L  E  G  G :495   
1321:  GTCCTCCCCCAGTGTGAGTGCCGCTGCGGGGACAGCAGCAAGGAGCGCAGCCTCTGCGGCAACAAGGGCTCCATGGAGTGCGGGGTCTGCAGGTGCGATGCCGGCTACATCGGGAAGCACTGCGAGTGCCAGACGCAGGGCCGGAGCAGCCAGGAGCTGGAAGGA  :1485  
          ¤           #              ¤                 ¤     ¤        ¤     ¤                                            ¤     ¤              ¤                       ¤              
 496:  S  C  R  K  D  N  S  S  I  I  C  S  G  L  G  D  C  I  C  G  Q  C  V  C  H  T  S  D  V  P  N  K  K  I  Y  G  Q  F  C  E  C  D  N  M  N  C  E  R  F  D  G  Q  V  C  G  G :550   
1486:  AGCTGCCGCAAGGACAACAGCTCCATCATCTGCTCGGGGCTGGGCGACTGCATCTGCGGGCAGTGCGTGTGCCACACGAGCGACGTGCCCAACAAGAAGATTTACGGCCAGTTCTGCGAGTGTGACAACATGAACTGCGAGCGCTTCGATGGCCAAGTCTGCGGG  :1650  
                         ¤     ¤        ¤     ¤                          ¤     ¤                    ¤                       ¤                 ¤     ¤        ¤     ¤                 
 551:  G  E  K  R  G  L  C  F  C  G  T  C  R  C  Q  E  G  F  E  G  S  A  C  Q  C  L  K  S  T  Q  G  C  L  N  L  Q  G  V  E  C  S  G  R  G  R  C  R  C  N  V  C  Q  C  D  F  F :605   
1651:  GGCGAGAAGCGGGGCCTCTGCTTCTGCGGCACCTGCAGGTGCCAAGAAGGCTTCGAGGGCTCGGCGTGCCAGTGCCTCAAGTCCACGCAGGGCTGCCTCAACCTGCAGGGCGTCGAGTGCAGCGGCCGCGGCCGGTGCCGCTGCAACGTGTGCCAGTGCGACTTT  :1815  
                         ¤        ¤        ¤           ¤                 ¤        ¤                                #  ¤           ¤                                                  
 606:  G  Y  Q  P  P  L  C  T  D  C  P  S  C  Q  V  P  C  A  R  Y  A  K  C  A  E  C  L  K  F  D  T  G  P  F  A  K  N  C  S  A  E  C  G  T  T  K  L  L  P  S  R  M  S  G  R   R:660   
1816:  GGCTACCAGCCGCCCCTGTGCACCGACTGCCCCAGCTGCCAGGTGCCCTGCGCCCGCTATGCCAAATGCGCCGAGTGCCTGAAGTTCGACACCGGCCCCTTCGCCAAAAACTGCAGCGCGGAGTGCGGGACCACCAAGCTGCTGCCCAGCCGGATGTCGGGCCGC  :1980  
          ¤                       ¤                                                                          ¤                                                                     
 661:  K  C  N  E  R  D  S  E  G  C  W  M  T  Y  F  L  V  Q  R  D  G  R  D  N  Y  D  L  H  V  E  E  T  R  E  C  V  K  G  P  N  I  A  A  I  V  G  G  T  V  G  G  V  V  L  V  V :715   
1981:  AAGTGCAATGAGCGGGACTCCGAGGGCTGCTGGATGACCTACTTCCTGGTGCAGCGCGACGGCCGGGACAACTACGACCTGCACGTGGAGGAGACGCGCGAGTGTGTGAAAGGCCCCAACATCGCCGCCATCGTGGGGGGCACCGTGGGGGGAGTCGTGCTCGTG  :2145  
                                                 +                                            +                                +     +  +  +                                         
 716:  G  I  F  L  L  A  I  W  K  V  L  T  H  L  S  D  L  R  E  Y  K  R  F  E  K  E  K  L  K  S  Q  W  N  N  D  N  P  L  F  K  S  A  T  T  T  V  M  N  P  K  F  A  E  R  *    :770   
2146:  GGCATCTTCCTGCTGGCCATCTGGAAGGTCCTGACCCACCTGAGTGACCTCAGGGAGTACAAGCGCTTCGAGAAGGAGAAGCTCAAGTCCCAGTGGAACAACGATAACCCCCTTTTCAAGAGCGCCACCACGACAGTTATGAACCCCAAGTTTGCTGAGCGCTAG  :2310 
                                                                                                                                                                                
Boxes framing the sequences represent the deduced different constitutive parts of the protein : the putative leader peptide ( ), PSI domain ( ), spacer (hybrid domain) 
( ),  β I-like domain ( ) with its MIDAS ( ), ADMIDAS ( ) and LIMBS ( ) sites, mid-region (hybrid domain) ( ), linker ( ), four EGF 
domains ( ), β-tail domain ( ), transmembrane region ( ), binding site of cytohesin ( ), Rack1 and α-actinin ( ). The six-stranded β-sheets and seven α-
helices of the β I-like domain are underlined. The important “C191PNKEKEC”, L732, S756, T758TT, F766 are framed in black boxes. Cysteine residues (¤), potential N-glycosylation sites 
(#) and potential cytoplasmic-tail phosphorylation sites (+) are marked at the top of the sequences. Sequence data have been deposited at GenBank under accession no. EF585977.Page 6 of 12
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BMC Veterinary Research 2007, 3:27 http://www.biomedcentral.com/1746-6148/3/27However, these two wild boar-specific CD11a isoforms
might display an altered/improved function compared to
those described among domestic pigs [45].
Characterization of WbCD18-encoding cDNA and 
deduced amino-acid sequence
The cDNA sequence of WbCD18 contains an ORF of 2310
bp [GenBank:EF585977] that codes for 769 aa (Fig. 3).
The mature WbCD18 contains a 22 aa putative leader
peptide (M1-S22), an extracellular domain of 679 residues
(Q23-N700), a single hydrophobic transmembrane region
of 23 residues (I701-W723) and a short cytoplasmic tail of
46 residues (K724-R769) (Fig. 3). Starting from the N-termi-
nal end, the extracellular region successively contains a
cysteine-rich repeats-containing analogue of the so-called
[54] plexin-semaphorin integrin domain (Q23-V74) [55], a
spacer (A75-K123) [55,56], an inserted I-like domain of 240
amino acids (G124-L363), a mid-region (S364-C445) that
fold-up with the spacer to form the hybrid domain
[55,56], a cysteine-rich region containing four EGF-like
regions (C449-E482, C483-E535, C536-Q574, and C575-T613)
[39,55,57], and a C-terminal β-tail domain [5] (D614-
N700) (Fig. 3). A putative metal ion-dependent adhesion
site (MIDAS)-like DXSXS motif (D134-M139), an adjacent
site to MIDAS (ADMIDAS) (D141, D142, E347), and a lig-
and-induced metal-binding site (LIMBS) (D173, N229,
D231, P233, E234) motif are predicted within the I-like
domain [58]. The cytoplasmic tail contains the binding
sites for cytohesin, Rack1 (K724VLT), and α-actinin
(K736RFEKEKLKSQ) [59]. Overall, the protein contains 58
cysteine residues and 5 N-linked putative glycosylation
sites (Asn-X-Thr/Ser), all located within the extracellular
region (Fig. 3).
WbCD18 comparison among species
Overall, the general organization of wild boar (Sus scrofa),
porcine (Sus scrofa domestica) [30], bovine (Bos taurus)
[60], water buffalo (Bubalus bubalis) (GenPept
AAW29104), caprine (Capra hircus) [61], ovine (Ovis aries
and Ovis canadensis) [62,63], human [64], canine (Canis
familiaris) [65], murine (Mus musculus) [66], rat (Rattus
norvegicus) [GenBank:NM_001037780], chicken (Gallus
gallus) [67], carp and channel catfish (Cyprinus carpio and
Ictalurus punctatus) [GenBank:AB031070] [68] CD18 pro-
teins is quite similar (Fig. 4). Sequence comparisons
between WbCD18 and its porcine, bovine, water buffalo,
caprine, ovine, human, canine, murine, rat, chicken, carp
and channel catfish counterparts shows respectively, 99%,
88%, 88%, 88%, 88%, 87%, 83%, 81%, 81%, 80%, 62%,
49% and 48% identity, and 99%, 93%, 93%, 93%, 93%,
93%, 90%, 89%, 88%, 88%, 76%, 64% and 63% similar-
ity (BLOSUM62 table) (Table 2). The MIDAS-like, ADMI-
DAS, LIMBS motifs, the I-like domain, the EGF-2 domain
and the cytoplasmic tail have the highest identity while
the putative peptide signal, the β-tail domain, and the
EGF-1 show the lowest identity (Table 2). The very high
interspecies conservation of the putative MIDAS-like,
ADMIDAS, LIMBS, I-like domains and the cytoplasmic
tail is consistent with an involvement of these regions in
the functional activities of β2-integrins. Overall, the high
evolutionary conservation of the I-like domain confirms
its importance in β2-integrins functions, which is compat-
ible with the observation that monoclonal antibodies
binding epitopes mapped within this region inhibit bind-
ing of LFA-1 to ICAMs 1–3 [56]. The maximum conserva-
tion being observed for the CD18 MIDAS-like motif, it is
tempting to speculate that it plays a fundamental role in
β2-integrin function. In this way, it was demonstrated that
the C169PNKEKEC sequence conserved among mamma-
lian species (Fig. 4) constitutively activates LFA-1 binding
to ICAM-1 [69]. LIMBS and ADMIDAS sites modulate
binding of ligand to the MIDAS-like in the integrins that
lack the αI domain [70-72] but the ADMIDAS seems also
to regulate αL I domain affinity and to participate in the
outside-in signalling [58]. The high degree of conserva-
tion in the cytoplasmic tail, with many Ser, Thr, and Tyr
residues, is compatible with the important role that phos-
phorylation of these residues plays in regulating adhesive
activity [73] and with the observation that cytoplasmic
domain truncation of CD18 markedly diminishes bind-
ing of LFA-1 to ICAM-1 [52]. Importantly, it was shown
that the phosphorylation of the highly conserved residues
T758, T759 and T760 plays a crucial role in the activation of
the receptor and the binding to ICAM-1 [59,74]. In addi-
tion, the key residue F766 for binding to ICAM-1 is strictly
conserved [59]. Although EGF-1 possesses a weaker iden-
tity, its similarity is very high (Table 2). The weaker con-
servation of the β-tail domain could translate a less degree
of importance of this domain for the CD18 function.
Every cysteine residue in the wild boar extracellular por-
tion of mature CD18 is present at the same location in
CD18 from other species, which is consistent with a role
in maintaining the global structure of the protein. Simi-
larly, all five potential Asn-glycosylation sites observed in
wild boar are present at the same location in other mam-
malian species. Wild boar-specific CD18 isoform is char-
acterized by two amino acid substitutions compared to
domestic pigs: G560S and A721V, which should not result
in structural differences, according to BLOSUM 62 table,
but might impact CD18 function.
Conclusion
This study reports the sequencing of the wild boar β2-
integrin CD11a/CD18 subunits cDNAs. Predicted CD11a
and CD18 subunits share all the main structural character-
istics of their mammalian homologues, with a larger inter-
species conservation for the CD18 than the CD11a.
Besides these strong overall similarities, wild boar and
domestic pig LFA-1 differ by 2 (CD18) and 1 or 3
(CD11a) substitutions, of which one is located in the cru-Page 7 of 12




































































Table 2: Between-species percent identities and similarities of CD18 constitutive blocks








































































































































































































































































































































































































































































































































Wb, Po, Bo, Bu, Cap, OvAr, OvCa, Hu, Can, Mu, Ra, Gal, Cyp, and Ict: wild boar, porcine, bovine, water buffalo, caprine, ovine (ovis aries), ovine (ovis canadensis), human, canine, murine, rat, chicken, carp, 
and channel catfish CD18, respectively ; PSI : plexin-semaphorin integrin ; MIDAS: metal-ion dependent adhesion site ; ADMIDAS : adjacent to MIDAS ; LIMBS : ligand-induced metal-binding site ; EGF : 
epidermal growth factor site; vs : versus. (1) identity; (2) similarity (BLOSUM62 table).
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Comparison of the wild boar (Wb-), porcine (Po-), bovine (Bo-), water buffalo (Bu-), caprine (Cap-), ovine (Ovis aries and canadensis) (OvAr- and OvCan-), human (Hu-), canine (Can-), murine (M -), rat (Ra-), chick n (Gal-), carp (Cyp-) and channel tfish (Ict-) β2 subunits amino acids seque cesFigure 4
Comparison of the wild boar (Wb-), porcine (Po-), bovine (Bo-), water buffalo (Bu-), caprine (Cap-), ovine (Ovis aries and 
canadensis) (OvAr- and OvCan-), human (Hu-), canine (Can-), murine (Mu-), rat (Ra-), chicken (Gal-), carp (Cyp-) and channel 
catfish (Ict-) β2 subunits amino acids sequences.
WbCD18    : MLCRCSPLLL-LVG--LLTLRSALSQE--CAKYKVSTCRDCIESGPGCAWCQKLNFSGQGEPDSVRCDTREQLLAKGCVADDIVDP-RSLAETQEDQAGGQK------QLSPQKVTLYLRPGQAATFNVTFRRAKGYPIDLYYLMDLSYS : 138 
PoCD18    : MLCRCSPLLL-LVG--LLTLRSALSQE--CAKYKVSTCRDCIESGPGCAWCQKLNFSGQGEPDSVRCDTREQLLAKGCVADDIVDP-RSLAETQEDQAGGQK------QLSPQKVTLYLRPGQAATFNVTFRRAKGYPIDLYYLMDLSYS : 138 
BoCD18    : MLRQRPQLLL-LAG--LLALQSVLSQE--CTNYKVSTCRDCIESGPGCAWCQKLNFTGQGEPDSIRCDTRAELLSKGCPADDIMEP-KSLAETRDSQAGSRK------QLSPQEVTLYLRPGQAVAFNVTFRRAKGYPIDLYYLMDLSYS : 138 
BuCD18    : MLRQRPQLLF-LSG--LLALQSVLSQE--CTKYKVSTCRDCIESGPGCAWCQKLNFTGQGEPDSLRCDTRAELLSKGCPADDIMEP-KSLAETRDSQADRQK------QLSPQEVTLYLRPGQAAAFNVTFRRAKGYPIDLYYLMDLSYS : 138 
CapCD18   : MLPQRPQLLL-LAG--LLALQSVLSQE--CTKYKVSTCRDCIESGPGCAWCQKLNFTGQGEPDSTRCDTRAQLLSKGCPADDIMEP-KSLAETRQSQAGKQK------QLSPEEVTLYLRPGQAAAFNVTFQRAKGYPIDLYYLMDLSYS : 138 
OvArCD18  : MLPQRPQLLL-LAG--LLSLQSVLSQE--CTKYKVSTCRDCIESGPGCAWCQKLNFTGQGEPDSTRCDTRAQLLSKGCPADDIMEP-KSLAETRQSQAGKQK------QLSPEEVTLYLRPGQAAAFNVTFQRAKGYPIDLYYLMDLSYS : 138 
OvCanCD18 : MLPQRPQLLL-LAG--LLSLQSVLSQE--CTKYKVSTCRDCIESGPSCAWCQKLNFTGQGEPDSTRCDTRAQLLSKGCPADDIMEP-KSLAETRQSQAGRQK------QLSPEEVTLYLRPGQAAAFNVTFQRAKGYPIDLYYLMDLSYS : 138 
HuCD18    : MLGLRPPLLA-LVG--LLSLGCVLSQE--CTKFKVSSCRECIESGPGCTWCQKLNFTGPGDPDSIRCDTRPQLLMRGCAADDIMDP-TSLAETQEDHNGGQK------QLSPQKVTLYLRPGQAAAFNVTFRRAKGYPIDLYYLMDLSYS : 138 
CanCD18   : ML-RHSSLLLTLEG--LLFLWAASCQE--CTKYKVSTCRDCVESGPGCAWCQKLNFTGLGEPDSVRCDTREQLLLKGCAADDIMDP-QSLAEIQEDKKGGRQ------QLSPQKVTLYLRPGQAAAFNVTFRRAKGYPIDLYYLMDLSYS : 132 
MuCD18    : MLGLRPSLLLALAG--LFFLGSAVSQE--CTKYKVSSCRDCIQSGPGCSWCQKLNFTGPGEPDSLRCDTRAQLLLKGCPADDIMDP-RSIANPEFDQRGQRK------QLSPQKVTLYLRPGQAAAFNVTFRRAKGYPIDLYYLMDLSYS : 139 
RaCD18    : MLGPH-TLLLILAG--LLFLGSALSEE--CTKYKVSNCRDCIQSGPGCSWCQKLNFTGPGEPDSLRCDTRAQLLLKGCPADDIMDP-KSFADLHPQYQVQRS------QLSPQKVTLNLRPGQAAAFNVTFRRAKGYPIDLYYLMDLSYS : 138 
GalCD18   : -MPRDCCLWLPAMTWVLLLLTTAFAAE--CPKIKVGTCKNCIQSGPGCAWCKKLSFTKAGEPDSNRCDTIEQLQQRGCPENEIEFPVNEIKRTQDSAFSNKI------QLTPQEVHLKLRIREPAEFDVKFRRATGYPIDIYYLMDLSYS : 141 
CypCD18   : -MLQAVCLRGLLL---LLVGRQVYTEQ--CLKASVNTCGDCIKSGPGCAWCKDLNFTKTGEQEAARCDTPAVLKEKGCPPTDIINPKNDFIKISNKPLKAGE---NPVQIQPQEIQLDLRPGMPYTFQLHFKRAQGYPVDLYYLMDLSYS : 141 
IctCD18   : -MPQAAKI--VLL---LLFGQYVYSQEKECIKSSVVSCKDCINSGPGCAWCQELNFTKTGEPEAVRCDTEEKLKEKGCSQQKIISPSSHLENVANKPLSGSDRTKNPVQVQPQEIKLNLRPGQAFTFNLQFKRAVGYPVDLYYLMDLSYS : 144 
              ¤ ¤¤¤                      ¤       ¤  ¤      ¤  ¤   #           ¤          ¤                                                 #                                
WbCD18    : MLDDLINVKKLGGDLLRALNEITESGRIGFGSFVDKTVLPFVNTHPEKLRNPCPNKEKECQAPFAFRHVLKLTDNSNQFQTEVGKQLISGNLDAPEGGLDAMMQVAACPEEIGWRNVTRLLVFATDDGFHFAGDGKLGAILTPNDGRCHL : 288 
PoCD18    : MLDDLINVKKLGGDLLRALNEITESGRIGFGSFVDKTVLPFVNTHPEKLRNPCPNKEKECQAPFAFRHVLKLTDNSNQFQTEVGKQLISGNLDAPEGGLDAMMQVAACPEEIGWRNVTRLLVFATDDGFHFAGDGKLGAILTPNDGRCHL : 288 
BoCD18    : MVDDLVNVKKLGGDLLRALNGITESGRIGFGSFVDKTVLPFVNTHPEKLRNPCPNKEKECQPPFAFRHVLKLTDNSKQFETEVGKQLISGNLDAPEGGLDAMMQVAACPEEIGWRNVTRLLVFATDDGFHFAGDGKLGAILTPNDGRCHL : 288 
BuCD18    : MVDDLINVKKLGGDLLRALNDITESGRIGFGSFVDKTVLPFVNTHPEKLRNPCPNKEKECQPPFAFRHVLKLTDNSKQFETEVGKQLISGNLDAPEGGLDAMMQVAACPEEIGWRNVTRLLVFATDDGFHFAGDGKLGAILTPNDGRCHL : 288 
CapCD18   : MVDDLANVKKLGGDLLRALNDITESGRIGFGSFVDKTVLPFVNTHPEKLRNPCPNKEKQCQPPFAFRHVLKLTDNSKQFETEVGKQLISGNLDAPEGGLDAMMQVAACPEEIGWRNVTRLLVFATDDGFHFAGDGKLGAILTPNDGRCHL : 288 
OvArCD18  : MVDDLANVKKLGGDLLRALNDITESGRIGFGSFVDKTVLPFVNTHPEKLRNPCPNKEKECQPPFAFRHVLKLTDNSKQFETEVGKQLISGNLDAPEGGLDAMMQVAACPEEIGWRNVTRLLVFATDDGFHFAGDGKLGAILTPNDGRCHL : 288 
OvCanCD18 : MVDDLANVKKLGGDLLRALNDITESGRIGFGSFVDKTVLPFVNTHPEKLRNPCPNKEKECQPPFAFRHVLKLTDNSKQFETEVGKQLISGNLDAPEGGLDAMMQVAACPEEIGWRNVTRLLVFATDDGFHFAGDGKLGAILTPNDGRCHL : 288 
HuCD18    : MLDDLRNVKKLGGDLLRALNEITESGRIGFGSFVDKTVLPFVNTHPDKLRNPCPNKEKECQPPFAFRHVLKLTNNSNQFQTEVGKQLISGNLDAPEGGLDAMMQVAACPEEIGWRNVTRLLVFATDDGFHFAGDGKLGAILTPNDGRCHL : 288 
CanCD18   : MLDDLINVKKLGGDLLRALNEITESGRIGFGSFVDKTVLPFVNTHPEKLKNPCPNKEKECQAPFAFRHVLKLTNNSNKFQTEVGKQLISGNLDAPEGGLDAMMQVAACPEQIGWRNVTRLLVFATDDGFHFAGDGKLGAILTPNDGRCHL : 282 
MuCD18    : MLDDLNNVKKLGGDLLQALNEITESGRIGFGSFVDKTVLPFVNTHPEKLRNPCPNKEKACQPPFAFRHVLKLTDNSNQFQTEVGKQLISGNLDAPEGGLDAIMQVAACPEEIGWRNVTRLLVFATDDGFHFAGDGKLGAILTPNDGRCHL : 289 
RaCD18    : MLDDLNNVKKLGGDLLQALNEITESGRIGFGSFVDKTVLPFVNTHPEKLRNPCPNKEKACQPPFAFRHVLKLTDNSNQFQTEVGKQLISGNLDAPEGGLDAIMQVAACPEEIGWRNVTRLLVFATDDGFHFAGDGKLGAILTPNDGRCHL : 288 
GalCD18   : MLDDLENVKKLGGQLLRALESTTPSRRIGFGSFVDKTVLPFVNTHPEKLKNPCPNKDSNCQPPFAFKHILSLTDNAEKFESEVGKQFISGNLDAPEG-LDAMMQAAVCGDLIGWRNVTRLLVYATDDGFHFAGDGKLGGILTPNDGQCHL : 290 
CypCD18   : MKDDLENVKNLGNDLLKELNKITGSARIGFGSFVDKTLLPYTDTNEAKLKRPCSDKNEPCQPAFGFQHVLPLTKDGDKFKSMVAEQHISGNLDPPEGSLDAIMQAAVCVNEIGWGNSTRLLVLATDDGFHMAGDGKLAAILEPNRETCQL : 291 
IctCD18   : MEDDLTNVKDLGIQILKRLQQITGNARIGFGSFVDKTLLPFTDTTEEKLKKPCPAKRKQCQPAFGYHHVLSLTQNETLFSTMVSGQEISGNLDTPEGGLDAIMQVATCVNKIGWGNSTRLLVLATDAGFHKAGDGKLAGILEPNQETCQL : 294 
                                                                ¤      ¤                                               ¤       #                               ¤            
WbCD18    : ED-NLYKSSNEFDYPSVGQLAHKLAESNIQPIFAVTKKMVKTYEKLTDIIPKSAVGELSEDSSNVVQLIKNAYNKLSSRVFLDHNALPDTLKVTYDSFCSNGVSQVNQPRGDCDGVQINVPITFQVKVTASECIQEQSFVIRALGFTDTV : 437 
PoCD18    : ED-NLYKSSNEFDYPSVGQLAHKLAESNIQPIFAVTKKMVKTYEKLTDIIPKSAVGELSEDSSNVLELIKNAYNKLSSRVFLDHNALPDTLKVTYDSFCSNGVSQVNQPRGDCDGVQINVPITFQVKVTASECIQEQSFVIRALGFTDTV : 437 
BoCD18    : ED-NLYKSSNEFDYPSVGQLAHKLAESNIQPIFAVTKKMVKTYEKLTEIIPKSAVGELSEDSRNVVELIKNAYNKLSSRVFLDHSTLPDTLKVTYDSFCSNGKSQVDQPRGDCDGVQINVPITFQVKVTATECIQQQSFTIRALGFTDTV : 437 
BuCD18    : ED-NLYKSGNEFDYPSVGQLAHKLAESNIQPIFAVTKKMVKTYEKLTEIIPKSAVGELSEDSKNVVELIKNAYNKLSSRVFLDHSTLPDTLKVTYDSFCSNRVSQVDQPRGDCDGVQINVPITFQVKVTATECIQQQSFTIRALGFTDTV : 437 
CapCD18   : ED-NLYKSSNEFDYPSVGQLAHKLAESNIQPIFAVTKKMVKTYEKLTEIIPKSAVGELSEDSKNVVELIKSAYNKLSSRVFLDHNTLPDTLKVAYDSFCSNGVSQVDQPRGDCDGVQINVPITFQVKVTATECIQEQSFTIRALGFTDTV : 437 
OvArCD18  : ED-NLYKSSNEFDYPSVGQLAHKLAESNIQPIFAVTKKMVKTYEKLTEIIPKSAVGELSEDSKNVVELIKSAYNKLSSRVFLDHNTLPDTLKVAYDSFCSNGVSQVDQPRGDCDGVQINVPITFQVKVTATECIQEQSFTIRALGFTDTV : 437 
OvCanCD18 : ED-NLYKSSNEFDYPSVGQLAHKLAESNIQPIFAVTKKMVKTYEKLTEIIPKSAVGELSEDSKNVVELIKSAYNKLSSRVFLDHNTLPDTLKVAYDSFCSNRVSQVDQPRGDCDGVQINVPITFQVKVTATECIQEQSFTIRALGFTDTV : 437 
HuCD18    : ED-NLYKRSNEFDYPSVGQLAHKLAENNIQPIFAVTSRMVKTYEKLTEIIPKSAVGELSEDSSNVVQLIKNAYNKLSSRVFLDHNALPDTLKVTYDSFCSNGVTHRNQPRGDCDGVQINVPITFQVKVTATECIQEQSFVIRALGFTDIV : 437 
CanCD18   : ED-NMYKRSNEFDYPSVGQLAHKLAESNIQPIFAVTKRMVTTYEKLTEVIPKSAVGELSDDSSNVVQLIKNAYNKLSSRVFLDHSLAPSTLKVTYDSFCSNGVSQVDQPRGDCDGVQINVPITFQVKVTATECIQEQSFIIRALGFTDTV : 431 
MuCD18    : ED-NMYKRSNEFDYPSVGQLAHKLSESNIQPIFAVTKKMVKTYEKLTEIIPKSAVGELSDDSSNVVQLIKNAYYKLSSRVFLDHSTLPDTLKVTYDSFCSNGASSIGKSRGDCDGVQINNPVTFQVKVMASECIQEQSFVIRALGFTDTV : 438 
RaCD18    : ED-NMYKRSNEFDYPSVGQLAHKLSESNIQPIFAVTKKMVKTYEKLTEIIPKSAVGELSDDSSNVVQLIKKAYYKLSSRVFLDHTTIPDTLKVTYDSFCNNRVSSIGKSRGDCDGVQINNPVTFQVKVTASECIQEQSFVIRALGFTDTV : 437 
GalCD18   : ED-NMYKKSNEFDYPSVGQLVQKLAENNIQPIFAVTSKMVDVYKKLSDMIPKSAVGELNEDSSNIIELIQVAYNNLSSRIILDHSTLPDVLDVKYDSICNNNTGAKNEARGQCDNVKINDEVTFKVKVTANECIKSQSFTIRPLGFTDTL : 439 
CypCD18   : VDRK-YSKSTLWDYPSVGQVARKLEEQNIQPIFAVTKKMETVYTELSKLIPKSAVGVLSEDSGNVVNLIVDAYNSLSSEVIMAHEALPEFISVKYTSNCKDGEKPSD--RGKCDNVNIGTEVVFDVTVTVDRCINSQSFLIGPLGFNEKL : 438 
IctCD18   : DNKNIYSMSNNWDYPSVGQIARKLGEETIQPIFAVTEDVSHIHQELSKLIPKSEVGVLSSDSSNVVKLIVDAYNKLSSNIIVTHDGLPEDISVTFTSNCPGGEKPSD--RGTCNNVAIGQGVTFSVTVKAAKCLDKAYFQTGPLGFSEKL : 442 
                                                                                                              ¤             ¤                   ¤
                                                                                                                                                                         
WbCD18    : TVRVLPQCECRCGDSSKE--RSLCGNKGSMECGVCRCDAGYIGKHCECQTQGRSSQELEGSCRKDNSSIICSGLGDCICGQCVCHTSDVPNKKIYGQFCECDNMNCERFDGQVCGGEKRGLCFCGTCRCQEGFEGSACQCLKSTQGCLNL : 585 
PoCD18    : TVRVLPQCECRCGDSSKE--RTLCGNKGSMECGVCRCDAGYIGKHCECQTQGRSSQELEGSCRKDNSSIICSGLGDCICGQCVCHTSDVPNKKIYGQFCECDNMNCERFDGQVCGGEKRGLCFCSTCRCQEGFEGSACQCLKSTQGCLNL : 585 
BoCD18    : TVRVLPQCECQCRDASRD--GSICGGRGSMECGVCRCDAGYIGKNCECQTQGRSSQELEGSCRKDNSSIICSGLGDCICGQCVCHTSDVPNKKIYGQFCECDNVNCERYDGQVCGGEKRGLCFCGTCRCDEQYEGSACQCLKSTQGCLNL : 585 
BuCD18    : TVRVLPQCECQCRDASRD--GSICGGRGSMECGVCKCDAGYIGKNCECQTQGRSSQELEGSCRKDNSSIICSGLGDCICGQCVCHTSDVPNKKIYGQFCECDNVNCERYDGQVCGGEKRGLCFCGTCRCDEQYEGSACQCLKSTQGCLNL : 585 
CapCD18   : TVRVLPQCECQCRDASRD--RSVCGGRGSMECGVCRCDAGYIGKNCECQTHGRSSQELEGSCRKDNSSIICSGLGDCICGQCVCHTSDVPNKKIYGQFCECDNVNCERYDGQVCGGEKRGLCFCGTCRCNEQHEGSACQCLKSTQGCLNL : 585 
OvArCD18  : TVRVLPQCECQCREASRD--RSVCGGRGSMECGVCRCDAGYIGKNCECQTHGRSSQELEGSCRKDNSSIICSGLGDCICGQCVCHTSDVPNKKIYGQFCECDNVNCERYDGQVCGGDKRGLCFCGTCRCNDQHEGSACQCLKSTQGCLNL : 585 
OvCanCD18 : TVRVLPQCECQCREASRD--RGVCGGRGSMECGVCRCDAGYIGKNCECQTHGRSSQELEGSCRKDNSSIICSGLGDCICGQCVCHTSDVPNKKIYGQFCECDNVNCERYDGQVCGGDKRGLCFCGACRCNDQYEGSACQCLKSTQGCLNL : 585 
HuCD18    : TVQVLPQCECRCRDQSRD--RSLCHGKGFLECGICRCDTGYIGKNCECQTQGRSSQELEGSCRKDNNSIICSGLGDCVCGQCLCHTSDVPGKLIYGQYCECDTINCERYNGQVCGGPGRGLCFCGKCRCHPGFEGSACQCERTTEGCLNP : 585 
CanCD18   : TVHVIPQCECQCRDVGQD--HGLCSGKGSLECGICRCEAGYIGKNCECLTHGRSSQELEGSCRRDNSSLICSGLGDCLCGQCVCHRSDVPNKNIFGRYCECDNVNCERYDGQVCGGKVRGSCNCGKCQCEQNYEGSACQCVKSTQGCLST : 579 
MuCD18    : TVQVRPQCECQCRDQSRE--QSLCGGKGVMECGICRCESGYIGKNCECQTQGRSSQELERNCRKDNSSIVCSGLGDCICGQCVCHTSDVPNKEIFGQYCECDNVNCERYNSQVCGGSDRGSCNCGKCSCKPGYEGSACQCQRSTTGCLNA : 586 
RaCD18    : TVQVHPQCECQCRDQSRM--RNLCGGKGVMECGICRCESGYIGKNCECQTQGRSSQELEGNCRKDNSSIVCSGLGDCICGQCVCHTSDIPNKVIFGQYCECDNFNCERYDGQVCGGLKRGSCSCGQCNCKEGFEGSACQCQRSTTGCLNA : 585 
GalCD18   : TVHLDSICDCDCREQP-D--PTACSGNGKVVCGICSCNLSYTGKNCECDTKGKTSKELEGSCRKDNSSVICSGLGDCVCGQCVCHTSDVPGKEIYGTFCDCDNMNCEFHNGSLCGGEERGRCDCGECKCTPKYEGSACQCKKSTDGCRNS : 586 
CypCD18   : KVNVRTRCDCECDDINQP--HPHCKEKGKVVCGSCRCDPGFLGQHCECQVGQKDVASLKAQCQKDNGTE-CEGKGDCVCGRCQCHLTE-GGNNFYGEFCECDDEHCEKYANKQCAGH--GKCKCGRCECNEGYEGAACQCAKSDEDC-KI : 581 
IctCD18   : KVNIKTRCECECD--NQPGVQLYCNQHGTIVCGTCSCVPGFLGQRCECSLGQKDEATLKAQCRKDNGTE-CEGRGDCECGVCKCHQTE-GGKSYYGPHCECDDEHCEKYQNKLCGGN--GDCRCGVCKCNEGYEGTACQCKKSNEFC-ET : 585 
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WbCD18    : QGVECSGRGRCRCNVCQCDFGYQPPLCTDCPSCQVPC-ARYAKCAECLKFDTGPFAKNCSAECGTTKLLPSRMSG-RKCNERDSEGCWMTYFLVQRDGRDNYDLHVEETRECVKGPNIAAIVGGTVGGVVLVGIFLLAIWKVLTHLSDLR : 733 
PoCD18    : QGVECSGRGRCRCNVCQCDFGYQPPLCTDCPSCQVPC-ARYAKCAECLKFDTGPFAKNCSAECGTTKLLPSRMSG-RKCNERDSEGCWMTYFLVQRDGRDNYDLHVEETRECVKGPNIAAIVGGTVGGVVLVGIFLLVIWKVLTHLSDLR : 733 
BoCD18    : DGVECSGRGRCRCNVCQCDPGYQPPLCSECPGCPVPC-AGFAPCTECLKFDKGPFAKNCSAACGQTKLLSSPVPG-RKCKERDSEGCWMTYTLVQRDGRDRYDVHVDDMLECVKGPNIAAIVGGTVGGVVLVGILLLVIWKALTHLSDLR : 733 
BuCD18    : DGVECSGRGRCRCNVCQCDPGYQPPLCSECPGCPVPC-AGFAPCTECLKFDKGPFAKNCSAACGQTKLLSSPVPG-RKCKERDSEGCWMTYTLVQRDGRDRYDVHVDDMLECVKGPNIAAIVGGTVGGVVLVGILLLVIWKALTHLSDLR : 733 
CapCD18   : DGVECSGRGRCRCNVCQCDPGYQPPLCIDCPGCPVPC-AGFAPCTECLKFDKGPFAKNCSAACGQTKLLSSPVPGGRKCKERDSEGCWMTYTLVQRDGRNRYDVHVDDMLECVKGPNIAAIVGGTVGGVVLVGILLLVIWKALTHLSDLR : 734 
OvArCD18  : DGVECSGRGRCRCNVCQCDPGYQPPLCIDCPGCPVPC-AGFAPCTECLKFDKGPFAKNCSAACGQTKLLSSPVPGGRKCKERDSEGCWMTYTLVQRDGRNRYDVHVDDMLECVKGPNIAAIVGGTVGGVVLVGILLLAIWKALTHLSDLR : 734 
OvCanCD18 : NGVECSGRGRCRCNVCQCDPGYQPPLCIDCPGCPVPC-AGFAPCTECLKFDKGPFAKNCSAACGQTKLLSSPVPGGRKCKERDSEGCWMTYTLVQRDGRNRYDVHVDDMLECVKGPNIAAIVGGTVGGVVLVGILLLAIWKALTHLSDLR : 734 
HuCD18    : RRVECSGRGRCRCNVCECHSGYQLPLCQECPGCPSPC-GKYISCAECLKFEKGPFGKNCSAACPGLQLSNNPVKG-RTCKERDSEGCWVAYTLEQQDGMDRYLIYVDESRECVAGPNIAAIVGGTVAGIVLIGILLLVIWKALIHLSDLR : 733 
CanCD18   : EGIECNGRGRCRCNVCECDGGYQPPLCGDCLGCPSPC-GRYITCAQCLKFKQGPSGRNCSVECGNVGLLSKPPEKGRRCKERDLEGCWITYTLRQRAGWDSYEIHVDDSRECVGGPQIAPIVGGTVSGVVLIGILLLAIWKALTHLSDLR : 728 
MuCD18    : RLVECSGRGHCQCNRCICDEGYQPPMCEDCPSCGSHCRDNHTSCAECLKFDKGPFEKNCSVQCAGMTLQTIPLKK-KPCKERDSEGCWITYTLQQKDGRNIYNIHVEDSLECVKGPNVAAIVGGTVVGVVLIGVLLLVIWKALTHLTDLR : 735 
RaCD18    : RLVECSGRGRCQCNRCICEKGYQPPLCEECPGCPLPC-STYVFCAECLKFDKGPFQKNCSVQCANVTLQTVPFKK-KPCKERDSEGCWITYTLQQKDG-NAYNIHVDDDRECVKGPNVAAIIGGTVAGVVLIGVLLLVIWKALTHLTDLN : 732 
GalCD18   : RQNECSLRGSCPCNRCQCRGGYQPPFCEECPGCPSPC-GRHISCVECKSFNSGPLAKNCSVACTSIQLADEPRAGSRQCKEKDSENCWISFYMAQDDGEEMYTVTVDPKKECPEPPNIALIVGSTIAGVALIGLLLLLTWRLLTEIFDRR : 735 
CypCD18   : DGIVCHERGKCVCNQCECQRGYKGPSCKVCPTCQRPCQES-GSCVECLAFGTGPFEKSCIENCKHLRHVMVEKLIKHDCRVKDKEGCWMLFTMTEELGFDKYIVNVLKDRECPEGPNIAAIVGGSIAAVALIGLLILLIIKAVLYASDLR : 730 
IctCD18   : GKTICHGRGKCVCNQCVCERRYKGITCETCPTCELPCQES-GSCVECNAFGTGPFEKTCNASCYHLDVEVVEKLAKRECQVKDNEGCRMIFSMTEQDGFDKYIVKVLKDRECPEGPNVALIVGGTLAGVALIGLLLLILIKALFYFKDLK : 734 
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WbCD18    : EYKRFEKEKLKSQWNN-DNPLFKSATTTVMNPKFAER- : 769 
PoCD18    : EYKRFEKEKLKSQWNN-DNPLFKSATTTVMNPKFAER- : 769 
BoCD18    : EYHRFEKEKLKSQWNN-DNPLFKSATTTVMNPKFAES- : 769 
BuCD18    : EYHRFEKEKLKSQWNN-DNPLFKSATTTVMNPKFAES- : 769 
CapCD18   : EYHRFEKEKLKSQWNN-DNPLFKSATTTVMNPKFAES- : 770 
OvArCD18  : EYHRFEKEKLKSQWNN-DNPLFKSATTTVMNPKFAES- : 770 
OvCanCD18 : EYHRFEKEKLKSQWNN-DNPLFKSATTTVMNPKFAES- : 770 
HuCD18    : EYRRFEKEKLKSQWNN-DNPLFKSATTTVMNPKFAES- : 769 
CanCD18   : EFKRFEKEKLRSQWNN-DNPLFKSATTTVMNPRFAES- : 764 
MuCD18    : EYRRFEKEKLKSQWNN-DNPLFKSATTTVMNPKFAES- : 771 
RaCD18    : EYRRFEKEKLKSQWNN-DNPLFKSATTTVMNPKFAES- : 768 
GalCD18   : EYRRFEKEKSKAKWNEADNPLFKSATTTVMNPRFDGQ- : 772 
CypCD18   : EWKRFEKD-RKHEKTSGTNPLFQNATTTVQNPTFSGDS : 767 
IctCD18   : EWKKFEKEAQRRQWAKGENPLFQNATTTVANPAFTGDS : 772 
                     + +   +       + +++     £+ ++ 
                                   £ £££
Black columns with white letter represent identity among the 14 species. Cysteine residues (¤), potential N-glycosylation sites (#) and potential cytoplasmic-tail phosphorylation sites (+) are marked at 
the bottom of the sequences in red for 100% identity and in blue for less. The important “C191PNKEKEC”, L732, S756, T758TT and F766 residues are marked by (£) in red for 100% identity and in blue for 
less. The stripes above the sequences represent the deduced different constitutive parts of the protein: the signal peptide ( ), PSI domain ( ), spacer (hybrid domain) ( ),  β I-like 
domain ( ) with its MIDAS ( ), ADMIDAS ( ) and LIMBS ( ) sites, mid-region (hybrid domain) ( ), linker ( ), four EGF domains ( , ), β-tail domain 
( ), transmembrane region ( ), binding site of cytohesin ( ), Rack1 and α-actinin ( ).
BMC Veterinary Research 2007, 3:27 http://www.biomedcentral.com/1746-6148/3/27cial I-domain (CD11a, E168D). As most wild boars are
seropositive to Actinobacillus pleuropneumoniae and
because they have sustained continuous natural selection,
future studies of the functional impact of these polymor-
phisms could bring interesting new information on the
physiopathology of pneumonia in domestic pigs.
Methods
RNA isolation
Total RNA from spleen of freshly slaughtered wild boars
(Sus scrofa) was extracted with TRIzol (Invitrogen, USA) as
described by the manufacturer.
Amplification and sequencing of the full length cDNA
Total RNA from spleen was reverse transcribed using
Improm II (Promega). The full-length cDNA was then
generated by long distance PCR using Taq and Pfu DNA
polymerase from the High Fidelity PCR Enzyme Mix (Fer-
mentas) with primers designed from the 5'- and 3'UTR of
PoCD11a [31] and PoCD18 [30]. The couple of primers
used for amplification of WbCD11a and WbCD18 are the
next: 5'GGTATGGTCCCTCCAGAAGC-3' (CD11a for-
ward), 5'-GCAGGCTGAGTCCAGTCCTG-3' (CD11a
reverse), 5'-GAGGTCTCCAGGACATCAAG-3' (CD18 for-
ward) and 5'-TAGGGGTGCTTGGTGAAGAC-3' (CD18
reverse). The procedures recommended by the manufac-
turer were applied, with the following cycling parameters
: 5 min at 94°C, then 35 cycles including (i) 30 s at 94°C,
(ii) 45 s at 60°C and (iii) 3 min 45 s at 72°C, and a final
extension at 72°C for 10 min. Resulting PCR products
were purified using the NucleoSpin®ExtractII kit (Mach-
erey-Nagel), and sequenced on a ABI-3100 Genetic Ana-
lyzer using the Big Dye terminator chemistry (Applied
Biosystems). The CD11a/CD18 cDNA sequences were
deduced from sequences obtained from four independent
wild boars. Sequences data have been deposited at Gen-
Bank under accession nos. EF585976 and EF585977.
Bioinformatics
Primers design was performed with Netprimer [75] and
Primer 3 [76]. Nucleotidic sequence and identity analyses
were carried out using respectively Chromas v.2.21 [77]
and BLAST programs [78]. Alignment of amino acids
sequences was drawn by GeneDoc v.2.6.002 [79] follow-
ing the BLOSUM 62 matrix. SignalP v.2.0.b2 [80] and
NetNGlyc v.1.0 [81] provided peptide signal and N-glyco-
sylation sites prediction, respectively. The secondary struc-
tures were resolved by the GOR secondary structure
prediction method version IV [82].
List of abbreviations
aa, amino acid ; ADMIDAS, adjacent to MIDAS ; Bo,
bovine; Can, canine ; Cap, caprine ; CD, cluster of differ-
entiation ; CR, complement receptor ; Cyp, Cyprinus ;
DCBM, divalent-cation binding motif ; EGF, epidermal
growth factor ; Gal, Gallus ; Hu, human; ICAM, intercellu-
lar adhesion molecule ; Ict, Ictalurus; LFA, lymphocyte
function-associated antigen; LIMBS, ligand-induced
metal-binding site; MIDAS, metal-ion dependent adhe-
sion site; Mu, murine; Ov, ovine ; OvAr, Ovis aries ;
OvCan, Ovis Canadensis ; Po, porcine ; Ra : rat ; PSI, plexin-
semaphorin integrin ; Si : simian, Wb : wild boar.
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